WO2014056844A1 - Ionic liquids based on oxalic acid mono esters - Google Patents

Ionic liquids based on oxalic acid mono esters Download PDF

Info

Publication number
WO2014056844A1
WO2014056844A1 PCT/EP2013/070824 EP2013070824W WO2014056844A1 WO 2014056844 A1 WO2014056844 A1 WO 2014056844A1 EP 2013070824 W EP2013070824 W EP 2013070824W WO 2014056844 A1 WO2014056844 A1 WO 2014056844A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
monomethyloxalate
butyl
alkyl
ethyl
Prior art date
Application number
PCT/EP2013/070824
Other languages
French (fr)
Inventor
Klemens Massonne
Joerg Sundermeyer
Axel BRAAM
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of WO2014056844A1 publication Critical patent/WO2014056844A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/36—Oxalic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Definitions

  • the present invention relates to monosubstituted oxalic acid derivatives of the general formula (I)
  • the present invention further relates to a process for the preparation of monosubstituted oxalic acid derivatives of the fomula (I) as defined above and the use of the monosubstituted oxalic acid derivatives of the general formula (I) above (without disclaimer) for at least partially dissolving an inorganic or an organic material such as metal compounds, e.g. rare earth element com- pounds or actinide element compounds or the use of the monosubstituted oxalic acid derivatives of the general formula (I) above (without disclaimer) in a separation process for metals such as rare earth elements or actinide elements , e.g. in a liquid-liquid extraction process for the separation of rare earth elements.
  • Monomethyl oxalates of some quaternized oganic ammonium compounds are known.
  • imidazolium based organic liquids having anions different from oxalic acid derivatives in e.g. lanthanide speciation is described in I Billard et al., Radiochim Acta (2009), 355- 359
  • the use of imidazolium based organic liquids having anions different from oxalic acid deriv- atives in extraction of e.g. lanthanides is described in I. Billard et al., Anal Bioanal Chem. (201 1 ) 1555-1566 and in X. Sun et al.Jalanta (2012), 132-137.
  • Ci to C30 organic residue means an organic structural moiety containing one (1 ) to thirty (30) carbon atoms.
  • the Ci to C30 organic residue is for example selected from the group consisting of the following organic residues (I) to (X).
  • alkyl comprises straight-chain or branched alkyl. This is preferably straight-chain or branched Ci-C3o-alkyl, in particular C1-C18- alkyl and very particularly preferably Ci-Ci2-alkyl.
  • alkyl groups are, in particular, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, 1 - methylbutyl, tert-pentyl, neopentyl, n-hexyl, 3-hexyl, 2-methyl-1 -pentyl, 3-methyl-1 -pentyl, 4- methyl-1 -pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3- methyl-3-pentyl, 2,2-dimethyl-1 -butyl, 2,3-dimethyl-1 -butyl, 3,3-dimethyl-1 -butyl, 2-ethyl-1 -butyl, 2,3-dimethyl-2-butyl, 3,3-
  • alkyl also comprises alkyl radicals whose carbon chain may be interrupted by one or more nonadjacent heteroatoms or heteroatom-comprising groups which are preferably selected from among -0-, -S-, -NR a -, -PR 3 -, -SiR a R aa and/or -SO2.
  • R a is preferably hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl or hetaryl.
  • R aa is preferably hydrogen, alkyl, cycloalkyl, heterocycloalkyl or aryl.
  • alkyl radicals whose carbon chains may be interrupted by one or two nonadjacent heteroatoms -O- are the following: methoxymethyl, diethoxymethyl, 2-methoxyethyl, 2-ethoxyethyl, 2-propoxyethyl, diethoxyethyl, 2-butoxyethyl, 2-octyloxyethyl, 2-methoxypropyl, 3-methoxypropyl, 3-ethoxypropyl, 3- propoxypropyl, 2-isopropoxyethyl, 2-butoxypropyl, 3-butoxypropyl, 4-methoxybutyl, 4- ethoxybutyl, 4-propoxybutyl, 6-methoxyhexyl, 3,6-dioxaheptyl (5-methoxy-3-oxapentyl),
  • alkyl radicals whose carbon chains may be interrupted by three or more than three nonadjacent heteroatoms -O- also include oligooxyalkylenes and polyoxyalkylenes, i.e. compounds having repeating units which are preferably selected from among (CH2CH20) x i,
  • x1 , x2 and x3 are each, independently of one another, an integer from 3 to 100, preferably from 3 to 80.
  • the sum of x1 , x2 and x3 is an integer from 3 to 300, in particular from 3 to 100.
  • the repeating units can be present in any order, i.e. they can be randomly distributed, alternating or block-like repeating units.
  • Examples are 3,6,9-trioxadecyl, 3,6,9-trioxaundecyl, 3,6,9-trioxadodecyl, 4,8,12-trioxatridecyl (1 1 -methoxy-4,8-dioxaundecyl), 4,8,12- trioxatetradecyl, 14-methoxy-5,10-dioxatetradecyl, 5, 10,15-trioxaheptadecyl, 3,6,9,12- tetraoxatridecyl, 3,6,9, 12-tetraoxatetradecyl, 4,8, 12,16-tetraoxaheptadecyl (15-methoxy-4,8, 12- trioxapentadecyl), 4,8, 12,16-tetraoxaoctadecyl and the like.
  • alkyl radicals whose carbon chains may be interrupted by one or more, e.g. 1 , 2, 3, 4 or more than 4, nonadjacent heteroatoms -S- are the following: butylthiomethyl, 2-methylthioethyl, 2-ethylthioethyl, 2-propylthioethyl, 2-butylthioethyl, 2- dodecylthioethyl, 3-methylthiopropyl, 3-ethylthiopropyl, 3-propylthiopropyl, 3-butylthiopropyl, 4-methylthiobutyl, 4-ethylthiobutyl, 4-propylthiobutyl, 3,6-dithiaheptyl, 3,6-dithiaoctyl,
  • alkyl radicals whose carbon chains are interrupted by one or two nonadjacent het- eroatom-comprising groups -NR a - are the following:
  • alkyl radicals whose carbon chains may be interrupted by three or more than three nonadjacent heteroatom-comprising groups - NR a - also include oligoalkylenimines and poly- alkylenimines.
  • alkyl radicals whose carbon chains are interrupted by one or more, e.g. 1 or 2, nonadjacent -S02- groups are 2-methylsulfonylethyl, 2-ethylsulfonylethyl, 2-propylsulfonylethyl, 2-isopropylsulfonylethyl, 2-butylsulfonylethyl, 2-methylsulfonyl propyl, 3-methylsulfonylpropyl, 2- ethylsulfonyl propyl, 3-ethylsulfonylpropyl, 2-propylsulfonylpropyl, 3-propylsulfonylpropyl, 2-butylsulfonyl propyl, 3-butylsulfonylpropyl, 2-methylsulfonylbutyl, 4-methylsulfonylbutyl, 2- ethylsulfonyl
  • alkyl also comprises substituted alkyl radicals.
  • Cycloalkyi, cycloalkyloxy, polycycloalkyl, polycycloalkyloxy, heterocycloalkyl, aryl and hetaryl substituents of the alkyi groups may in turn be unsubstituted or substituted; suitable substituents are those mentioned below for these groups.
  • alkyi also applies in principle to the alkyi parts of alkoxy, alkylamino, dialkylamino, alkylthio (alkylsulfanyl), alkylsulfinyl, alkylsulfonyl, etc.
  • Suitable substituted alkyi radicals are the following: alkyi substituted by carboxy, e.g. carboxymethyl, 2-carboxyethyl, 3-carboxypropyl,
  • alkyi substituted by SO3H e.g. sulfomethyl, 2-sulfoethyl, 3-sulfopropyl, 4-sulfobutyl,
  • alkyi substituted by carboxylate for example alkoxycarbonylalkyl, e.g. methoxycarbonylmethyl, ethoxycarbonylmethyl, n-butoxycarbonylmethyl, 2-methoxycarbonylethyl, 2-ethoxycarbonylethyl,
  • alkyi substituted by cyano e.g. 2-cyanoethyl, 3-cyanopropyl, 3-cyanobutyl and 4-cyanobutyl
  • alkyi substituted by halogen as defined below where the hydrogen atoms in the alkyi group may be partly or completely replaced by halogen atoms, e.g. Ci-Ci8-fluoroalkyl, e.g.
  • Ci- Ci8-chloroalkyl e.g.
  • cyclopentyl methyl, 2-cyclopentylethyl, 3-cyclopentylpropyl, cyclohexylmethyl, 2-cyclohexylethyl, 3-cyclohexylpropyl and the like; alkyl substituted by 0 (oxo group), e.g.
  • alkyl substituted by NR a , preferably a group of the type in which R a is hydrogen or Ci-C4-alkyl, e.g.
  • Alkoxy is an alkyl group bound via an oxygen atom.
  • alkoxy are: methoxy, ethoxy, n-propoxy, 1 -methylethoxy, butoxy, 1 -methylpropoxy, 2-methylpropoxy, 1 ,1 -dimethylethoxy, n- pentoxy, 1 -methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1 ,1 -dimethylpropoxy, 1 ,2- dimethylpropoxy, 2,2-dimethylpropoxy, 1 -ethylpropoxy, hexoxy, 1 -methylpentoxy, 2- methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1 ,1 -dimethylbutoxy, 1 ,2-dimethylbutoxy, 1 ,3- dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1 -ethylbutoxy, 2-ethylbutoxy, 1 ,1 ,2-trimethyl
  • Alkylthio (alkylsulfanyl) is an alkyl group bound via a sulfur atom. Examples of alkylthio are me- thylthio, ethylthio, propylthio, butylthio, pentylthio and hexylthio.
  • Aryl-substituted alkyl radicals (“arylalkyl”) have at least one unsubstituted or substituted aryl group as defined below. Suitable substituents on the aryl group are those mentioned below.
  • the alkyl group in "arylalkyl” can bear at least one further substituent as defined above and/or be interrupted by one or more nonadjacent heteroatoms or heteroatom-comprising groups selected from among -0-, -S-, -NRa- and -S02-.
  • Arylalkyl is preferably phenyl-C1 -C10-alkyl, particularly preferably phenyl-C1 -C4-alkyl, e.g.
  • benzyl 1 -phenethyl, 2-phenethyl, 1 -phenprop-1 -yl, 2- phenprop-1 -yl, 3-phenprop-1 -yl, 1 -phenbut-1 -yl, 2-phenbut-1 -yl, 3-phenbut-1 -yl, 4-phenbut-1 -yl, 1 -phenbut-2-yl, 2-phenbut-2-yl, 3-phenbut-2-yl, 4-phenbut-2-yl, 1 -(phenmeth)-eth-1 -yl,
  • alkenyl comprises straight-chain and branched alkenyl groups which can, depending on the length oft the chain, have one or more double bonds (e.g. 1 , 2, 3, 4 or more than 4). Preference is given to C2-Cis-alkenyl, particularly preferably C2-Ci2-alkenyl groups.
  • alkenyl also comprises substituted alkenyl groups which may bear one or more (e.g. 1 , 2, 3, 4, 5 or more than 5) substituents.
  • alkenyl also comprises alkenyl radicals whose carbon chain may be interrupted by one or more nonadjacent heteroatoms or heteroatom-comprising groups which are preferably selected from among -0-, -S-, -NR a - and -SO2-.
  • Alkenyl is then, for example, ethenyl (vinyl), 1 -propenyl, 2-propenyl, 1 -methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1 -pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1 -hexenyl, 2-hexenyl, 3- hexenyl, 4-hexenyl, 5-hexenyl, penta-1 ,3-dien-1 -yl, hexa-1 ,4-dien-1 -yl, hexa-1 ,4-dien-3-yl, hexa- 1 ,4-dien-6-yl, hexa-1 ,5-dien-1 -yl, hexa-1 ,5-dien-3-yl, hexa-1 ,5-dien-4-yl, hepta-1 ,4-die
  • cycloalkyl comprises both un- substituted and substituted monocyclic saturated hydrocarbon groups which generally have from 3 to 12 ring carbons, (C3-Ci2-cycloalkyl groups) such as cyclopropyl, cyclobutyl, cyclopen- tyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl or cyclododecyl, in particular C5-Ci2-cycloalkyl.
  • Suitable substituents are generally selected from among the substituents mentioned above for alkyl groups, alkoxy and alkylthio.
  • Substituted cycloalkyl groups can have one or more (e.g. 1 , 2, 3, 4, 5 or more than 5) substituents, and in the case of halogen the cycloalkyl radical is partially or completely substituted by halogen.
  • cycloalkyl groups are cyclopentyl, 2- and 3-methylcyclopentyl, 2- and
  • Cycloalkyloxy is a cycloalkyl group as defined above bound via oxygen.
  • cycloalkenyl comprises unsubstituted and substituted, singly or doubly unsaturated hydrocarbon groups having from 3 to 5, up to 8, up to 12, preferably from 5 to 12, ring carbons, e.g. cyclopent-1 -en-1 -yl, cyclopent-2-en-1 -yl, cyclopent-3-en-1 -yl, cyclohex-1 -en- 1 -yl, cyclohex-2-en-1 -yl, cyclohex-3-en-1 -yl, cyclohexa-2,5-dien-1 -yl and the like. Suitable sub- stituents are those mentioned above for cycloalkyl.
  • Cycloalkenyloxy is a cycloalkenyl group as defined above bound via oxygen.
  • polycyclyl comprises in the broadest sense compounds which comprise at least two rings, regardless of how these rings are linked. These can be carbocyclic and/or heterocyclic rings. The rings can be saturated or unsaturated. The rings can be linked via a single or double bond ("multiring compounds") joined by fusion (“fused ring systems”) or bridged (“bridged ring systems", “cage compounds”). Preferred polycyclic compounds are bridged ring systems and fused ring systems. Fused ring systems can be aromatic, hydroaromatic and cyclic compounds joined by fusion (fused compounds).
  • Fused ring systems comprise two, three or more than three rings.
  • ortho- fusion i.e. each ring shares an edge or two atoms with each adjacent ring
  • peri-fusion in which a carbon atom belongs to more than two rings.
  • fused ring systems preference is given to ortho-fused ring systems.
  • bridged ring systems include systems which do not belong to the multiring ring systems nor to the fused ring systems and in which at least two ring atoms belong to at least two different rings.
  • bicyclo, tricyclo, tetra- cyclo compounds, etc. which comprise two, three, four, etc., rings.
  • the expression "bicycloal- kyl” comprises bicyclic hydrocarbon radicals which preferably have from 5 to 10 carbon atoms, e.g.
  • the expression "bicy- cloalkenyl” comprises monounsaturated, bicyclic hydrocarbon radicals which preferably have from 5 to 10 carbon atoms, e.g. bicyclo[2.2.1 ]hept-2-en-1 -yl.
  • aryl comprises aromatic hydro- carbon radicals which have one or more rings and may be unsubstituted or substituted.
  • the term aryl generally refers to hydrocarbon radicals having from 6 to 10, up to 14, up to 18, preferably from 6 to 10, ring carbons.
  • Aryl is preferably unsubstituted or substituted phenyl, naph- thyl, anthracenyl, phenanthrenyl, naphthacenyl, chrysenyl, pyrenyl, etc., and particularly preferably phenyl or naphthyl.
  • Substituted aryls can, depending on the number and size of their ring systems, have one or more (e.g.
  • substituents 1 , 2, 3, 4, 5 or more than 5) substituents. These are preferably selected independently from among alkyl, alkoxy, cycloalkyl, cycloalkyloxy, heterocycloalkyl, aryl, aryloxy, arylthio, hetaryl, halogen, hydroxy, SH, alkylthio, alkylsulfinyl, alkylsulfonyl, COOH, carboxylate, SO3H, sulfonate, NE 5 E 6 , nitro and cyano, where E 5 and E 6 are each, independently of one another, hydrogen, alkyl, cycloalkyl, cycloalkyloxy, polycyclyl, polycyclyloxy, heterocyclo- alkyl, aryl, aryloxy or hetaryl.
  • Aryl is particularly preferably phenyl which, if it is substituted, can generally bear 1 , 2, 3, 4 or 5 substituents, preferably 1
  • Aryl which bears one or more radicals is, for example, 2-, 3- and 4-methylphenyl, 2,4-, 2,5-, 3,5- and 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2-, 3- and 4-ethylphenyl, 2,4-, 2,5-, 3,5- and 2,6- diethylphenyl, 2,4,6-triethylphenyl, 2-, 3- and 4-propylphenyl, 2,4-, 2,5-, 3,5- and 2,6- dipropylphenyl, 2,4,6-tripropylphenyl, 2-, 3- and 4-isopropylphenyl, 2,4-, 2,5-, 3,5- and
  • aryloxy refers to aryl bound via an oxygen atom.
  • arylthio refers to aryl bound via a sulfur atom.
  • heterocycloalkyl comprises nonaromatic, unsaturated or fully saturated, cycloaliphatic groups which generally have from 5 to 8 ring atoms, for example 5 or 6 ring atoms, and in which 1 , 2 or 3 of the ring carbons have been replaced by heteroatoms selected from among oxygen, nitrogen, sulfur and an -NR a - group and which are unsubstituted or substituted by one or more, for example, 1 , 2, 3, 4, 5 or 6, Ci-C6-alkyl groups.
  • heterocycloaliphatic groups examples include pyrrolidinyl, piperidinyl, 2,2,6,6-tetramethylpiperidinyl, imidazolidinyl, pyrazolidinyl, oxazolidinyl, morpholidinyl, thiazoli- dinyl, isothiazolidinyl, isoxazolidinyl, piperazinyl, tetrahydrothienyl, dihydrothienyl, tetrahydro- furanyl, dihydrofuranyl, tetrahydropyranyl, 1 ,2-oxazolin-5-yl, 1 ,3-oxazolin-2-yl and dioxanyl.
  • Nitrogen-comprising heterocycloalkyl can in principle be bound either via a carbon atom or via a nitrogen atom.
  • heteroaryl (hetaryl) comprises unsubstituted or substituted, heteroaromatic groups which have one or more rings and generally have from 5 to 14 ring atoms, preferably 5 or 6 ring atoms, in which 1 , 2 or 3 of the ring carbons have been replaced by one, two, three or four heteroatoms selected from among O, N, -NR a - and S, e.g.
  • the substituents are generally selected from among Ci-C6-alkyl, Ci-C6-alkoxy, hydroxy, carboxy, halogen and cyano.
  • 5- to 7-membered nitrogen-comprising heterocycloalkyl or heteroaryl radicals which may optionally comprise further heteroatoms are, for example, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, pyrrolidinyl, pyrazolinyl, pyrazolidinyl, imidazolinyl, imidazolidinyl, pyridinyl, pyridazinyl, pyrimidi- nyl, pyrazinyl, triazinyl, piperidinyl, piperazinyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, indolyl, quinolinyl, isoquinolinyl or quinaldinyl which may be unsubsti
  • carboxylate and sulfonate are preferably a derivative of a carboxylic acid function or a sulfonic acid function, in particular a metal carboxylate or sulfonate, a carboxylic ester or sulfonic ester function or a carboxamide or sulfonamide function.
  • esters with Ci-C4-alkanols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol and tert-butanol.
  • acyl refers to alkanoyl, hetaroyl or aroyl groups which generally have from 1 to 1 1 , preferably from 2 to 8, carbon atoms, for ex- ample the formyl, acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, 2-ethylhexanoyl, 2-propylheptanoyl, benzoyl or naphthoyl group.
  • Halogen is fluorine, chlorine, bromine or iodine herein.
  • Suitable monosubstituted oxalic acid derivatives of the general formula (I) have a molar mass of less than 1000 g/mol, preferably less than 600 g/mol and in particular less than 400 g/mol.
  • [A] + is a cation made from an organic moiety A having a formally positively charged heteroatom selected from the group consisting of nitrogen, phosphorus and sulfur, preferably from nitrogen and phosphorus.
  • the organic moiety which contains the formally positively charged heteroatom can be linear or cyclic.
  • the organic moiety which contains a nitrogen atom as formally positively charged heteroatom is preferably cyclic and does for example include the respective com- pounds mentioned under the groups (VII) and (VIII) above.
  • the organic moiety which contains a nitrogen atom as formally positively charged heteroatom is more preferably a five-membered heterocycle having one formally positively charged nitrogen atom and may further contain one or more other heteroatoms which are not formally positively charged. Notwithstanding the foregoing the following compounds are disclaimed as compounds (I) as such, however not their use as described below is disclaimed:
  • [A] + is selected from among the compounds of the formulae (IV. a) to (IV.z), however not including [A] + of the above disclaimed compounds to the extent they relate to the composition of matter claims:
  • R is a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under groups (I) to (VIII) above, for example substituted or unsubstituted “alkyl”, “arylalkyl”, “alkenyl”, “cycloalkyl”, “cycloalkenyl”, “polycyclyl”, “aryl”, “ar- yloxy”, “arylthio”, “heterocycloalkyl”,”heteroarayl”, very preferably a straight chain or branched C1 to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl” residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl; radicals R 1 , R 2 , R 3
  • radicals carboxylate, sulfonate, acyl, alkoxycarbonyl, halogen, NE 1 E 2 , alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkenyl, cy- cloalkyi, cycloalkyloxy, cycloalkenyl, cycloalkenyloxy, polycydyl, polycyclyloxy, heterocycloalkyi, aryl, aryloxy or heteroaryl, what has been said above applies in full.
  • Radicals R 1 to R 9 in the abovementioned formulae (IV) which are bound to a carbon atom and have a heteroatom or a heteroatom-comprising group can also be bound directly via a heteroatom to the carbon atom. If two adjacent radicals R 1 to R 9 together with the ring atoms to which they are bound form at least one fused-on, saturated, unsaturated or aromatic ring or a ring system having from 1 to 30 carbon atoms, where the ring or ring system can have from 1 to 5 nonadjacent heteroatoms or heteroatom-comprising groups and the ring or the ring system may be unsubstituted or substituted, these radicals can together as fused-on building blocks preferably be 1 ,3-propylene, 1 ,4- butylene, 1 ,5-pentylene, 2-oxa-1 ,3-propylene, 1 -oxa-1 ,3-propylene, 2-oxa-1 ,3-propylene
  • the radical R is for example - unsubstituted Ci-Cis-alkyl such as methyl, ethyl, 1 -propyl, 2-propyl, 1 -butyl, 2-butyl, 2- methyl-1 -propyl (isobutyl), 2-methyl-2-propyl (tert-butyl), 1 -pentyl, 2-pentyl, 3-pentyl, 2- methyl-1 -butyl, 3-methyl-1 -butyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 2,2-dimethyl-1 -propyl, 1 -hexyl, 2-hexyl, 3-hexyl, 2-methyl-1 -pentyl, 3-methyl-1 -pentyl, 4-methyl-1 -pentyl, 2- methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3-methyl-3- pentyl, 2,2-d
  • Ci-Cis-alkyl substituted by one or more hydroxy, halogen, phenyl, cyano, C1-C6- alkoxycarbonyl and/or SO3H groups, especially hydroxy-Ci-Ci8-alkyl such as
  • phenyl-Ci-Cis-alkyl such as benzyl, 3-phenylpropyl
  • cyano-Ci-Cis-alkyl such as 2-cyanoethyl
  • Ci-C6-alkoxy-Ci-Ci8-alkyl such as 2- (methoxycarbonyl)ethyl, 2-(ethoxycarbonyl)ethyl or 2-(n-butoxycarbonyl)ethyl
  • C1-C18- fluoroalkyl such as trifluoromethyl, difluoromethyl, fluoromethyl, pentafluoroethyl, hep- tafluoropropyl, heptafluoroisopropyl, nonafluorobutyl, nonafluoroisobutyl, undecylfluoro- pentyl, undecylfluoroisopentyl
  • oligoalkylene and polyalkylene glycols such as polyethylene glycols and polypropylene glycols and their oligomers having 2 to 100 units and a hydrogen or a Ci-Cs-alkyl as end group, for example
  • C2-C6-alkenyl such as vinyl or propenyl.
  • radicals R 1 to R 9 each being, independently of one another, hydrogen;
  • Ci-Ci8-alkyl which is unsubstituted or substituted as defined above and/or may, as defined above, be interrupted by at least one heteroatom or heteroatom-comprising group;
  • C2-Ci8-alkenyl which is unsubstituted or substituted as defined above and/or may, as defined above, be interrupted by at least one heteroatom;
  • heterocycloalkyi having 5 or 6 ring atoms, where the ring comprises, apart from ring car- bons, 1 , 2 or 3 heteroatoms or heteroatom-comprising groups selected from among oxygen, nitrogen, sulfur and NR a and is unsubstituted or substituted as defined above;
  • heteroaryl having from 5 to 10 ring atoms, where the ring has, apart from ring carbons, 1 , 2 or 3 heteroatoms or heteroatom-comprising groups selected from among oxygen, nitrogen, sulfur and NR a and is unsubstituted or substituted as defined above.
  • R 1 to R 9 are alkoxy, then R 1 to R 9 are preferably methoxy or ethoxy or
  • R 1 to R 9 are acyl, then R 1 to R 9 are preferably formyl or Ci-C4-alkylcarbonyl, in particular formyl or acetyl.
  • R 1 to R 9 are Ci-Cis-alkyl
  • R 1 to R 9 are preferably unsubstituted Ci-Cis-alkyl such as me- thyl, ethyl, 1 -propyl, 2-propyl, 1 -butyl, 2-butyl, 2-methyl-1 -propyl (isobutyl), 2-methyl-2-propyl (tert-butyl), 1 -pentyl, 2-pentyl, 3-pentyl, 2-methyl-9-butyl, 3-methyl-1 -butyl, 2-methyl-2-butyl, 3- methyl-2-butyl, 2, 2-dimethyl-1 -propyl, 1 -hexyl, 2-hexyl, 3-hexyl, 2-methyl-1 -pentyl, 3-methyl-1 - pentyl, 4-methyl-1 -pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-
  • 3-methylaminopropyl 4-methylaminobutyl, 6-methylaminohexyl; di(Ci-C6-alkyl)-Ci-Ci8-alkyl such as 2-dimethylaminoethyl, 2-dimethylaminopropyl,
  • 3-dimethylaminopropyl 4-dimethylaminobutyl, 6-dimethylaminohexyl, cyano-Ci-Ci8-alkyl such as 2-cyanoethyl, 2-cyanopropyl,
  • Ci-Cio-alkoxy-Ci-Ci8-alkyl such as methoxymethyl, 2-methoxyethyl, 2-methoxypropyl,
  • Ci-Ci2-alkylsulfanyl-Ci-Ci8-alkyl such as butylthiomethyl, 2-dodecylthioethyl, C5-Ci2-cycloalkyl-Ci-Ci8-alkyl such as cyclopentylmethyl, 2-cyclopentylethyl,
  • phenyl-Ci-Cis-alkyl where the phenyl part of phenyl-Ci-Cis-alkyl is unsubstituted or substituted by one, two, three or four substituents selected independently from among Ci-C6-alkyl, halogen, Ci-C6-alkoxy and nitro, e.g.
  • benzyl (phenylmethyl), 1 -phenylethyl, 2-phenylethyl, 3-phenylpropyl, p-tolylmethyl, 1 -(p-butylphenyl)ethyl, p-chlorobenzyl, 2,4-dichlorobenzyl, p-methoxybenzyl, m-ethoxybenzyl, phenyl-C(CH3)2-, 2,6-dimethylphenylmethyl, diphenyl-Ci-Ci8-alkyl such as diphenylmethyl (benzhydryl); triphenyl-Ci-Ci8-alkyl such as triphenylmethyl; phenoxy-Ci-Ci8-alkyl such as 2-phenoxyethyl, 2-phenoxypropyl, 3-phenoxypropyl,
  • R 1 to R 9 are C2-Cis-alkenyl
  • R 1 to R 9 are preferably each C2-C6-alkenyl such as vinyl, 2- propenyl, 3-butenyl, cis-2-butenyl, trans-2-butenyl or C2-Cis-alkenyl which may be partially or completely substituted by fluorine.
  • R 1 to R 9 are C6-Cio-aryl, then R 1 to R 9 are each preferably phenyl or naphthyl, where phenyl or naphthyl is unsubstituted or substituted by one, two, three or four substituents selected independently from among halogen, Ci-Cis-alkyl, Ci-C6-alkoxy, Ci-C6-alkylsulfanyl, Ci-C6-alkoxy-Ci- C6-alkyl, Ci-C6-alkylcarbonyl, amino, Ci-C6-alkylamino, di(Ci-C6-dialkyl)amino and nitro, e.g.
  • phenyl methylphenyl (tolyl), dimethylphenyl (xylyl) such as 2,6-dimethylphenyl, trimethylphenyl such as 2,4,6-trimethylphenyl, ethylphenyl, diethylphenyl, isopropylphenyl, tert-butylphenyl, do- decylphenyl, chlorophenyl, dichlorophenyl, trichlorophenyl, fluorophenyl, difluorophenyl, trifluor- ophenyl, tetrafluorophenyl, pentafluorophenyl, 2,6-dichlorophenyl, 4-bromophenyl, methoxy- phenyl, dimethoxyphenyl, ethoxyphenyl, hexyloxyphenyl, 2,6-dimethoxyphenyl, 2-nitrophenyl, 4-nitrophenyl, 2,4-dinitropheny
  • R 1 to R 9 are C5-Ci2-cycloalkyl, then R 1 to R 9 are preferably each unsubstituted cycloalkyl such as cyclopentyl or cyclohexyl;
  • C5-Ci2-cycloalkyl which is substituted by one or two substituents selected independently from among Ci-C6-alkyl, Ci-C6-alkoxy, Ci-C6-alkylsulfanyl and chlorine, e.g. butylcyclohexyl, methox- ycyclohexyl, dimethoxycyclohexyl, diethoxycyclohexyl, butylthiocyclohexyl, chlorocyclohexyl, dichlorocyclohexyl, dichlorocyclopentyl; C5-Ci2-cycloalkyl which is completely or fully fluorinated.
  • substituents selected independently from among Ci-C6-alkyl, Ci-C6-alkoxy, Ci-C6-alkylsulfanyl and chlorine, e.g. butylcyclohexyl, methox- ycyclohexyl, dimethoxycyclohexyl,
  • R 1 to R 9 are polycyclyl, then R 1 to R 9 are each preferably C5-Ci2-bicycloalkyl such as nor- bornyl or C5-Ci2-bicycloalkenyl such as norbornenyl.
  • R 1 to R 9 are C5-Ci2-cycloalkenyl
  • R 1 to R 9 are each preferably unsubstituted cycloal- kenyl such as cyclopent-2-en-1 -yl, cyclopent-3-en-1 -yl, cyclohex-2-en-1 -yl, cyclohex-1 -en-1 -yl, cyclohexa-2,5-dien-1 -yl or partially or completely fluorinated cycloalkenyl.
  • R 1 to R 9 are heterocycloalkyl having 5 or 6 ring atoms, then R 1 to R 9 are each preferably 1 ,3- dioxolan-2-yl, 1 ,3-dioxan-2-yl, 2-methyl-1 ,3-dioxolan-2-yl, 4-methyl-1 ,3-dioxolan-2-yl.
  • R 1 to R 9 are heteroaryl, then R 1 to R 9 are each preferably furyl, thienyl, pyrryl, pyridyl, indolyl, benzoxazolyl, benzimidazolyl, benzothiazolyl. If hetaryl is substituted, it bears 1 , 2 or 3 substitu- ents selected independently from among Ci-C6-alkyl, Ci-C6-alkoxy and halogen, for example dimethylpyridyl, methylquinolyl, dimethylpyrryl, methoxyfuryl, dimethoxypyridyl or difluoropyridyl.
  • radicals R 1 to R 9 each being, independently of one another, - hydrogen;
  • Ci-Cis-alkyl which may be unsubstituted or substituted by one or more hydroxy, halogen, phenyl, cyano, Ci-C6-alkoxycarbonyl and/or sulfo groups, for example methyl, ethyl, 1 -propyl, 2-propyl, 1 -butyl, 2-butyl, 2-methyl-1 -propyl (isobutyl), 2- methyl-2-propyl (tert-butyl), 1 -pentyl, 2-pentyl, 3-pentyl, 2-methyl-1 -butyl, 3-methyl-1 -butyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 2,2-dimethyl-1 -propyl, 1 -hexyl, 2-hexyl, 3-hexyl, 2- methyl-1 -pentyl, 3-methyl-1 -pentyl, 4-methyl-1 -pentyl, 2-methyl-2-
  • 2-(n-butoxycarbonyl)ethyl trifluoromethyl, difluoromethyl, fluoromethyl, pentafluoroethyl, heptafluoropropyl, heptafluoroisopropyl, nonafluorobutyl, nonafluoroisobutyl, un- decylfluoropentyl, undecylfluoroisopentyl, 6-hydroxyhexyl and 3-sulfopropyl;
  • oligoalkylene and polyalkylene glycols such as polyethylene glycols and polypropylene glycols and their oligomers having from 2 to 100 units and a hydrogen or a Ci-Cs-alkyl as end group, for example
  • N,N-di-Ci-C6-alkylamino such as ⁇ , ⁇ -dimethylamino and N,N-diethylamino.
  • radicals R 1 to R 9 each being, independently of one another, hydrogen; Ci-Cis-alkyl such as methyl, ethyl, 1 -butyl, 1 -pentyl, 1 -hexyl, 1 -heptyl,
  • R is a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under groups (I) to (VIII) above, for example substituted or unsub- stituted “alkyl”, “arylalkyl”, “alkenyl”, “cycloalkyl”, “cycloalkenyl”, “polycyclyl”, “aryl”, “ar- yloxy”, “arylthio”, “heterocycloalkyl”,”heteroarayl”, very preferably a straight chain or branched Ci to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl” residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
  • radicals R 1 to R 5 are methyl, ethyl or chlorine and the remaining radicals R 1 to R 5 are each hydrogen;
  • R 3 is dimethylamino and the remaining radicals R 1 , R 2 , R 4 and R 5 are each hydrogen;
  • R 2 is carboxy or carboxamide and the remaining radicals R 1 , R 2 , R 4 and R 5 are each hydrogen; or
  • R 1 and R 2 or R 2 and R 3 are 1 ,4-buta-1 ,3-dienylene and the remaining radicals R 1 , R 3 , R 4 and R 5 are each hydrogen;
  • radicals R 1 to R 5 are methyl or ethyl and the remaining radicals R 1 to R 5 are each hydrogen.
  • pyridinium ions (IVa) are pyridinium, 2-methylpyridinium,
  • radicals R 1 to R 4 are each hydrogen or
  • one of the radicals R 1 to R 4 is methyl or ethyl and the remaining radicals R 1 to R 4 are each hydrogen.
  • R 1 is hydrogen, methyl or ethyl and R 2 to R 4 are each, independently of one another, hydrogen or methyl, or
  • R 1 is hydrogen, methyl or ethyl and R 2 and R 4 are each methyl and R 3 is hydrogen.
  • R 1 is hydrogen, methyl or ethyl and R 2 to R 4 are each, independently of one another, hydrogen or methyl, or
  • R 1 is hydrogen, methyl or ethyl and R 2 and R 4 are each methyl and R 3 is hydrogen, or
  • R 1 to R 4 are each methyl or
  • R 1 to R 4 are each hydrogen.
  • R 1 is hydrogen, methyl, ethyl, 1 -propyl, 1 -butyl, 1-pentyl, 1 -hexyl, 1-octyl, dodecyl,
  • 2-hydroxyethyl or 2-cyanoethyl and R 2 to R 4 are each, independently of one another, hydrogen, methyl or ethyl.
  • imidazolium ions are 1 -methylimidazolium, 1-ethylimidazolium, 1-(1- propyl)imidazolium, 1-(1-allyl)imidazolium, 1-(1-butyl)imidazolium, 1-(1-octyl)imidazolium, 1-(1- dodecyl)imidazolium, 1-(1-tetradecyl)imidazolium, 1-(1-hexadecyl)imidazolium, 1,3- dimethylimidazolium, 1,3-diethylimidazolium, 1-ethyl-3-methylimidazolium, 1-(1-butyl)-3- methylimidazolium, 1 -(1 -butyl)-3-ethylimidazolium, 1 -(1 -hexyl)-3-methylimidazolium, 1 -(1 -hexyl)-3-methylimid
  • Especially suitable imidazolium ions (IVe) are 1 ,3-diethylimidazolium, 1 -ethyl-3-methylimidazolium, 1 -(n-butyl)-3- methylimidazolium.
  • Particularly preferred pyrazolium ions (IVf), (IVg) and (IVg') are those in which R 1 is hydrogen, methyl or ethyl and R 2 to R 4 are each, independently of one another, hydrogen or methyl.
  • R 1 to R 4 are each, independently of one another, hydrogen or methyl.
  • pyrazolium ions mention may be made of pyrazolium and
  • R 1 to R 6 are each, independently of one another, hydrogen or methyl.
  • R 1 is hydrogen, methyl, ethyl or phenyl and R 2 to R 6 are each, independently of one another, hydrogen or methyl.
  • Particularly preferred 3-pyrazolinium ions (IVk) and (IVk') are those in which
  • R 1 and R 2 are each, independently of one another, hydrogen, methyl, ethyl or phenyl and R 3 to
  • R 6 are each, independently of one another, hydrogen or methyl.
  • imidazolinium ions (IV I) are those in which
  • R 1 and R 2 are each, independently of one another, hydrogen, methyl, ethyl, 1 -butyl or phenyl and R 3 and R 4 are each, independently of one another, hydrogen, methyl or ethyl and R 5 and R 6 are each, independently of one another, hydrogen or methyl.
  • imidazolinium ions (IVm) and (IVm') are those in which
  • R 1 and R 2 are each, independently of one another, hydrogen, methyl or ethyl and R 3 to R 6 are each, independently of one another, hydrogen or methyl.
  • Particularly preferred imidazolinium ions (IVn) and (IVn') are those in which
  • R 1 to R 3 are each, independently of one another, hydrogen, methyl or ethyl and R 4 to R 6 are each, independently of one another, hydrogen or methyl.
  • Particularly preferred thiazolium ions (IVo) and (IVo') and oxazolium ions (IVp) are those in which
  • R 1 is hydrogen, methyl, ethyl or phenyl and R 2 and R 3 are each, independently of one another, hydrogen or methyl.
  • 1 ,2,4-Triazolium ions (IVq), (IVq') and (IVq") used in the process of the invention are particularly preferably those in which
  • R 1 and R 2 are each, independently of one another, hydrogen, methyl, ethyl or phenyl and R 3 is hydrogen, methyl or phenyl.
  • Particularly preferred 1 ,2,3-triazolium ions (IVr), (IVr') and (IVr") are those in which
  • R 1 is hydrogen, methyl or ethyl
  • R 2 and R 3 are each, independently of one another, hydrogen or methyl or R 2 and R 3 are together 1 ,4-buta-1 ,3-dienylene.
  • R 1 is hydrogen, methyl, ethyl, butyl or phenyl and R 2 to R 9 are each, independently of one another, hydrogen or methyl.
  • R 1 and R 4 are each, independently of one another, hydrogen, methyl, ethyl or phenyl and R 2 , R 3 and R 5 to R 8 are each, independently of one another, hydrogen or methyl.
  • R 1 to R 5 are methyl, ethyl or butyl.
  • guanidinium ions IVv
  • Particularly preferred cholinium ions (IVw) are those in which
  • R 1 and R 2 are each, independently of one another, methyl, ethyl, 1 -butyl or 1 -octyl and R 3 is hydrogen, methyl, ethyl, acetyl, -SO2OH or -PO(OH)2, or
  • R 1 is methyl, ethyl, 1 -butyl or 1 -octyl
  • R 2 is a -CH2-CH2-OR 4 group
  • R 3 and R 4 are each, independently of one another, hydrogen, methyl, ethyl, acetyl, -SO2OH or -PO(OH)2, or
  • R 1 is a -CH2-CH2-OR 4 group
  • R 2 is a -CH2-CH2-OR 5 group
  • R 3 to R 5 are each, independently of one another, hydrogen, methyl, ethyl, acetyl, -SO2OH or -PO(OH)2.
  • R 3 is selected from among hydrogen, methyl, ethyl, acetyl, 5-methoxy-3-oxapentyl, 8-methoxy-3,6-dioxaoctyl, 1 1 - methoxy-3,6,9-trioxaundecyl, 7-methoxy-4-oxaheptyl, 1 1 -methoxy-4,8-dioxaundecyl, 15- methoxy-4,8,12-trioxapentadecyl, 9-methoxy-5-oxanonyl, 14-methoxy-5,10-oxatetradecyl, 5- ethoxy-3-oxapentyl, 8-ethoxy-3,6-dioxaoctyl, 1 1 -ethoxy-3,6,9-trioxaundecyl, 7-ethoxy-4- ox
  • the cations (IV.x.1 ) are particularly preferably selected from among cations of
  • DBN 1 ,5-diazabicyclo[4.3.0]non-5-ene
  • DBU 1 ,8-diazabicyclo[5.4.0]undec-7-ene
  • Particularly preferred phosphonium ions (IVy) are those in which
  • R 1 to R 3 are each, independently of one another, Ci-Cis-alkyl, in particular methyl, butyl, isobu- tyl, 1 -hexyl or 1 -octyl, or phenyl which is unsubstituted or bears 1 , 2, 3, 4 or 5 substituents selected independently from among Ci-Cis-alkyl, carboxylate, sulfonate, COOH and SO3H.
  • Particularly preferred sulfonium ions (IVz) are those in which
  • R 1 and R 2 are each, independently of one another, Ci-Cis-alkyl, in particular butyl, isobutyl,
  • the imidazolium ions imidazolinium ions, pyr- rolidinium ions, guanidinium ions and phosphonium ions are preferred.
  • [A] + cations are selected amongst the following groups (i) to (iv):
  • R is a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under groups (I) to (VIII) above, for example substituted or unsubstituted “alkyl”, “arylalkyl”, “alkenyl”, “cycloalkyl”, “cycloalkenyl”, “polycyclyl”, “aryl”, “ar- yloxy”, “arylthio”, “heterocycloalkyl”,”heteroarayl”, very preferably a straight chain or branched Ci to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl” residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
  • R 1 is hydrogen, methyl, ethyl, 1 -propyl, 1 -butyl, 1 -pentyl, 1 -hexyl, 1 -octyl, dodecyl,
  • 2- hydroxyethyl or 2-cyanoethyl and R 2 to R 4 are each, independently of one another, hydrogen, methyl or ethyl.
  • imidazolium ions are 1 -methylimidazolium, 1 -ethylimidazolium, 1 -(1 - propyl)imidazolium, 1 -(1 -allyl)imidazolium, 1 -(1 -butyl)imidazolium, 1 -(1 -octyl)imidazolium, 1 -(1 - dodecyl)imidazolium, 1 -(1 -tetradecyl)imidazolium, 1 -(1 -hexadecyl)imidazolium, 1 ,3- dimethylimidazolium, 1 ,3-diethylimidazolium, 1 -ethyl-3-methylimidazolium, 1 -(1 -butyl)-3- methylimidazolium, 1 -(1 -butyl)-3-ethylimidazolium,
  • Especially suitable imidazolium ions (IVe) are 1 ,3-diethylimidazolium, 1 -ethyl-3-methylimidazolium, 1 -(n-butyl)-3- methylimidazolium.
  • R 1 is hydrogen, methyl, ethyl, butyl or phenyl and R 2 to R 9 are each, independently of one another, hydrogen or methyl.
  • R 1 to R 5 are methyl, ethyl or butyl.
  • guanidinium ions IVv
  • men- tion may be made of ⁇ , ⁇ , ⁇ ', ⁇ ' -tetrabutyl-N",N'-'dimethylguanidinium, ⁇ , ⁇ , ⁇ ' , ⁇ ' , ⁇ '' -Pentabutyl- N " -methylguanidinium, N,N,N ' ,N ' -Tetrabutyl-N " -ethyl-N " -methylguanidinium
  • R 1 to R 3 are each, independently of one another, Ci-Cis-alkyl, in particular methyl, butyl, isobu- tyl, 1 -hexyl or 1 -octyl, or phenyl which is unsubstituted or bears 1 , 2, 3, 4 or 5 substituents selected independently from among Ci-Cis-alkyl, carboxylate, sulfonate, COOH and SO3H.
  • X is in general formula (I) a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under (I) to (X) above, for example substituted or unsubstituted “alkyl”, “alkyl”, “arylalkyl”, “alkenyl”, “cycloalkyl”, “cycloalkenyl”, “polycyclyl”, “aryl”, “ar- yloxy”, “arylthio", “heterocycloalkyl”,”heteroarayl”, all as defined herein, most preferably a straight chain or branched Ci to C30 alkyl; examples of the alkyl are given herein under the definition of "alkyl” in (I).
  • Examples for suitable monosubstituted oxalic acid derivatives of the general formula (I) are those wherein A is selected from the group consisting of the above defined compounds IV. a to IV.z and X is selected from the group consisting of straight chain or branched C1-C30 alkyl.
  • Examples for very suitable monosubstituted oxalic acid derivatives of the general formula (I) are those wherein A is selcted from the group consisting of the above defined compounds IV.e (im- idazolium), IVs (pyrrolidinium), IVv (guanidinium) , IVy (phosphonium) and X is selected from the group consisting of unsubstituted straight chain or branched Ci to C30 alkyl residues, preferably as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
  • Examples for preferred monosubstituted oxalic acid derivatives of the general formula (I) are those, wherein A is selected from the group consisting of the above described compounds IV.e (imidazolium) and X is selected from the group consisting of of unsubstituted straight chain or branched Ci to C30 alkyl residues, preferably as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
  • Monosubstituted oxalic acid derivatives of the general formula (I) are preferably in the state of an ionic liquid.
  • ionic liquids are organic salts which are liquid at temperatures below 180 °C, preferably below 130 °C, very preferably below 75 °C, most preferably below 25 °C.
  • the melting points of the oxalic acid derivatives of the general formula (I) are in a range of from - 50 °C to 180 °C, more preferably in the range of from - 20 °C to 130 °C.
  • oxalic acid derivatives of the general formula (I) are prepared by the reaction of an oxalic acid compound of the general formula (II)
  • R 1 has the meaning of R as defined above, including all modes.
  • R 1 and X can be the same or different.
  • at least one of R 1 and X is a straight chain or branched Ci to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl" residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecylvery preferably at least one of R 1 and X is methyl, ethyl, propyl, butyl, dodecyl most preferably at least one of R 1 and X is methyl, ethyl, propyl, in particular R 1 and X are me- thyl. Examples for oxalic acid derivatives of the general formula (II) are described in the section vent
  • the monosubstituted oxalic acid derivatives of the general formula (I) can be used to at least partially dissolve inorganic or organic material, for example metal compounds such as compounds of rare earth elements or actinide elements.
  • the monosubstituted oxalic acid derivatives of the general formula (I) can be used in a separation process for metals, in a separation process for rare earth elements and actinide elements, for example in liquid-liquid extraction processes for the separation of metals for example the separation of rare earth elements from each other.
  • IR: v 2956 (m), 2931 (m), 2871 (m), 1677 (s), 1535 (s), 1457 (m), 1433 (m), 1378 (w), 1314 (w), 1270 (s), 1 174 (w), 1 1 10 (w), 1066 (s), 940 (w), 891 (w), 843 (m), 739 (w) crrr 1 .
  • IR: v 2956 (m), 2932 (m), 2871 (m), 1770 (w), 1715 (m), 1635 (s), 1578 (m), 1537 (s), 1458 (m), 1418 (m), 1364 (m), 1317 (w), 1249 (w), 1216 (m), 1 185 (w), 1 157 (s), 1 1 12 (w), 1062 (w), 991 (w), 940 (w), 891 (w), 852 (w), 800 (w), 752 (m) cm “1 .
  • IR: v 2958 (w), 2873 (w), 1715 (m), 1628 (s), 1568 (m), 1461 (w), 1370 (m), 1 195 (m), 1 168 (s), 980 (w), 858 (w), 755 (m), 654 (w), 625 (w), 409 (w) cm "1 .
  • IR: v 2998 (w), 2880 (w), 1710 (m), 1623 (s), 1563 (s), 1540 (m), 1507 (w), 1440 (w), 1386 (m), 1369 (m), 1241 (w), 1 190 (s), 1 164 (s), 1063 (w), 1028 (w), 965 (m), 943 (m), 860 (m), 840 (m), 805 (w), 751 (s), 639 (w), 614 (w), 506 (m) cm-1 .
  • IR: v 2960 (m), 2876 (w), 1712 (s), 1629 (s), 1464 (m), 1369 (m), 1 192 (s), 1 165 (s), 1063 (w), 980 (m), 930 (m), 857 (w), 806 (w), 754 (s) cm “1 .
  • IR: v 2958 (m), 2932 (m), 2872 (w), 1716 (m), 1630 (s), 1463 (w), 1367 (m), 1310 (w), 1 189 (m), 1 162 (s), 1098 (w), 987 (w), 941 (m), 856 (w), 817 (w), 753 (m), 722 (w) cm "1 .
  • N-Butylpyrrolidine (0.34 g, 2.66 mmol) and dodecylmethyloxalat (0.62 g, 2.42 mmol) in 3 mL of acetonitrile were stirred for six days at 86 °C, washed with hexanes and dried in vacuo. 0.69 g (74 %) of a yellow solid were obtained. The melting point is below 100 °C.
  • N-Dodecylpyrrolidine (0.35 g, 1.47 mmol) and dodecylmethyloxalat (0.37 g, 1 .35 mmol) were stirred in 2 mL acetonitril at 90 °C for four days, washed with hexanes and dried in vacuo.
  • v / crrv 1 3064 (w), 2954 (w), 2918 (s), 2849 (m), 1771 (w), 1746 (w), 1705 (m), 1626 (s), 1559 (w), 1506 (w), 1465 (w), 1396 (w), 1373 (w), 1315 (w), 1285 (w), 1228 (w), 1 179 (s), 1 165 (s), 1 108 (w), 1076 (w), 1015 (w), 986 (w), 961 (w), 905 (w), 878 (w), 815 (w), 794 (w), 767 (w), 749 (w), 723 (w), 661 (w), 631 (w), 530 (w), 471 (w).
  • the above experiments indicate that the IL can discriminate rare earth chlorides at least exem- plified here by the different solubility of samariumtrichloride versus the trichlorides of lanthanum or neodymium.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Monosubstituted oxalic acid derivatives of the general formula (I) [A]+[O-C(O)-C(O)-O-X]-, wherein the meaning is: for [A]+, a cation made from an organic moiety A having a formally positively charged heteroatom selected from the group consisting of nitrogen, phosphorus and sulfur, X is a C1 to C30 organic residue, and wherein the following compounds (I) are disclaimed:tetramethylammonium monomethyloxalate methyltri(alkyl)ammonium monomethyloxalate trimethyl(1-hydroxyethyl)ammonium monomethyloxalate methyltriethylammonium monomethyloxalate tetraethylammonium monomethyloxalate n-propyltriethylammonium mono-n-propyloxalate n-butyltriethylammonium mono-n-butyloxalate benzyltriethylammonium monobenzyloxalate cyclohexyldimethylammonium monomethyloxalate dimethyl-phenylammonium monomethyloxalate. Tetrabutylammonium monomethyloxalate N-methylpyridinium monomethyloxalate N-ethylpyridinium monoethyloxalate N-n-propylpyridinium mono-n-propyloxalate N-n-butylpyridinium mono-n-butyl-oxalate N-benzylpyridinium monobenzyloxalate N-methyl-isochinolinium monomethyloxalate N-ethyl-isochinolinium monoethyloxalate N-n-propyl-isochinoliniummono-n-propyloxalate N-n-butyl-isochinolinium mono-n-butyloxalate N-benzyl-isochinolinium monobenzyloxalate.

Description

Ionic liquids based on oxalic acid mono esters
Description The present invention relates to monosubstituted oxalic acid derivatives of the general formula (I)
[A]+ [0-C(0)-C(0)-0-X]- (I) wherein the meaning is for
[A]+ a cation made from an organic moiety A having a formally positively charged heteroatom selected from the group consisting of nitrogen, phosphorus and sulfur, X is a Ci to C30 organic residue and wherein the following compounds (I) are disclaimed to the extent they relate to the composition of matter claims: Tetramethylammonium monomethyloxalate
Methyltri(alkyl)ammonium monomethyloxalate
Trimethyl(1 -hydroxyethyl)ammonium monomethyloxalate
Methyltriethylammonium monomethyloxalate
Tetraethylammonium monomethyloxalate
n-Propyltriethylammonium mono-n-propyloxalate
n-Butyltriethylammonium mono-n-butyloxalate
Benzyltriethylammonium monobenzyloxalate
cyclohexyldimethylammonium monomethyloxalate
Dimethyl-phenylammonium monomethyloxalate.
Tetrabutylammonium monomethyloxalate
N-methylpyridinium monomethyloxalate
N-ethylpyridinium monoethyloxalate
N-n-propylpyridinium mono-n-propyloxalate
N-n-butylpyridinium mono-n-butyl-oxalate
N-benzylpyridinium monobenzyloxalate
N-methyl-isochinolinium monomethyloxalate
N-ethyl-isochinolinium monoethyloxalate
N-n-propyl-isochinolinium mono-n-propyloxalate
N-n-butyl-isochinolinium mono-n-butyloxalate
N-benzyl-isochinolinium monobenzyloxalate. The present invention further relates to a process for the preparation of monosubstituted oxalic acid derivatives of the fomula (I) as defined above and the use of the monosubstituted oxalic acid derivatives of the general formula (I) above (without disclaimer) for at least partially dissolving an inorganic or an organic material such as metal compounds, e.g. rare earth element com- pounds or actinide element compounds or the use of the monosubstituted oxalic acid derivatives of the general formula (I) above (without disclaimer) in a separation process for metals such as rare earth elements or actinide elements , e.g. in a liquid-liquid extraction process for the separation of rare earth elements. Monomethyl oxalates of some quaternized oganic ammonium compounds are known.
The reaction of trimethylamine with oxalic acid dimethylester to the quaternary ammonium salt with a melting point of 125 °C is described by Willstatter and Kahn in Ber. Chem. Gesell. 1902, 35, 2757. The reaction of one of the amines pyridine, isoquinoline, triethylamine or N,N-dimethyl-2- aminoethanol with symmetrical oxalic acid esters [R-0-C(0)-C(0)-R], wherein R is methyl, ethyl, n-propy, n-butyl or benzyl, to the quaternary ammonium salts is described by Kametani et al. in J. Heterocyl. Chem. 1966, 3, 129. The reaction of pyridine with oxalic acid dimethylester to the quaternary ammonium salt is described by Kametani et al. in Yakugaku zasshi 1968, 88, 445 and by Dolenk and Modec in Acta Chim. Slov. 2008, 55, 752.
The preparation of quaternary ammonium salts from tertiary amines bearing alkyl substituents and oxalic acid dimethylester or oxalic acid diethylester is described in EP 2 033 945 A.
The use of imidazolium based organic liquids having anions different from oxalic acid derivatives in e.g. lanthanide speciation is described in I Billard et al., Radiochim Acta (2009), 355- 359, the use of imidazolium based organic liquids having anions different from oxalic acid deriv- atives in extraction of e.g. lanthanides is described in I. Billard et al., Anal Bioanal Chem. (201 1 ) 1555-1566 and in X. Sun et al.Jalanta (2012), 132-137.
None of these state of the art does disclose the use of the monosubstituted oxalic acid derivatives of the general formula (I) above (without disclaimer) for at least partially dissolving an inor- ganic or an organic material such as metal compounds, e.g. rare earth element compounds or actinide element compounds or the use of the monosubstituted oxalic acid derivatives of the general formula (I) above (without disclaimer) in a separation process for metals such as rare earth elements or actinide elements , e.g. in a liquid-liquid extraction process for the separation of rare earth elements.
An object of the instant invention is to provide new ionic compounds and their use in dissolution and separation processes for inorganic or organic materials. For the purpose of the present invention the expression Ci to C30 organic residue means an organic structural moiety containing one (1 ) to thirty (30) carbon atoms.
The Ci to C30 organic residue is for example selected from the group consisting of the following organic residues (I) to (X).
(I) For the purposes of the present invention, the expression "alkyl" comprises straight-chain or branched alkyl. This is preferably straight-chain or branched Ci-C3o-alkyl, in particular C1-C18- alkyl and very particularly preferably Ci-Ci2-alkyl. Examples of alkyl groups are, in particular, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, 1 - methylbutyl, tert-pentyl, neopentyl, n-hexyl, 3-hexyl, 2-methyl-1 -pentyl, 3-methyl-1 -pentyl, 4- methyl-1 -pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3- methyl-3-pentyl, 2,2-dimethyl-1 -butyl, 2,3-dimethyl-1 -butyl, 3,3-dimethyl-1 -butyl, 2-ethyl-1 -butyl, 2,3-dimethyl-2-butyl, 3,3-dimethyl-2-butyl, n-heptyl, n-octyl, 1 -methylheptyl, 2-ethylhexyl, 2,4,4- trimethyl-pentyl, 1 ,1 ,3,3-tetramethylbutyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl and n-eicosyl.
The expression alkyl also comprises alkyl radicals whose carbon chain may be interrupted by one or more nonadjacent heteroatoms or heteroatom-comprising groups which are preferably selected from among -0-, -S-, -NRa-, -PR3-, -SiRaRaa and/or -SO2. Ra is preferably hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl or hetaryl. Raa is preferably hydrogen, alkyl, cycloalkyl, heterocycloalkyl or aryl.
Examples of alkyl radicals whose carbon chains may be interrupted by one or two nonadjacent heteroatoms -O- are the following: methoxymethyl, diethoxymethyl, 2-methoxyethyl, 2-ethoxyethyl, 2-propoxyethyl, diethoxyethyl, 2-butoxyethyl, 2-octyloxyethyl, 2-methoxypropyl, 3-methoxypropyl, 3-ethoxypropyl, 3- propoxypropyl, 2-isopropoxyethyl, 2-butoxypropyl, 3-butoxypropyl, 4-methoxybutyl, 4- ethoxybutyl, 4-propoxybutyl, 6-methoxyhexyl, 3,6-dioxaheptyl (5-methoxy-3-oxapentyl),
3.6- dioxaoctyl (7-methoxy-4-oxaheptyl), 4,8-dioxanonyl (7-methoxy-4-oxaheptyl), 3,7-dioxaoctyl,
3.7- dioxanonyl, 4,7-dioxaoctyl, 4,7-dioxanonyl, 2- and 4-butoxybutyl, 4,8-dioxadecyl, 9-ethoxy- 5-oxanonyl. Examples of alkyl radicals whose carbon chains may be interrupted by three or more than three nonadjacent heteroatoms -O- also include oligooxyalkylenes and polyoxyalkylenes, i.e. compounds having repeating units which are preferably selected from among (CH2CH20)xi,
(CH(CH3)CH20)x2 and ((CH2)40)X3, where x1 , x2 and x3 are each, independently of one another, an integer from 3 to 100, preferably from 3 to 80. The sum of x1 , x2 and x3 is an integer from 3 to 300, in particular from 3 to 100. In polyoxyalkylenes having two or three different repeating units, the repeating units can be present in any order, i.e. they can be randomly distributed, alternating or block-like repeating units. Examples are 3,6,9-trioxadecyl, 3,6,9-trioxaundecyl, 3,6,9-trioxadodecyl, 4,8,12-trioxatridecyl (1 1 -methoxy-4,8-dioxaundecyl), 4,8,12- trioxatetradecyl, 14-methoxy-5,10-dioxatetradecyl, 5, 10,15-trioxaheptadecyl, 3,6,9,12- tetraoxatridecyl, 3,6,9, 12-tetraoxatetradecyl, 4,8, 12,16-tetraoxaheptadecyl (15-methoxy-4,8, 12- trioxapentadecyl), 4,8, 12,16-tetraoxaoctadecyl and the like.
Examples of alkyl radicals whose carbon chains may be interrupted by one or more, e.g. 1 , 2, 3, 4 or more than 4, nonadjacent heteroatoms -S- are the following: butylthiomethyl, 2-methylthioethyl, 2-ethylthioethyl, 2-propylthioethyl, 2-butylthioethyl, 2- dodecylthioethyl, 3-methylthiopropyl, 3-ethylthiopropyl, 3-propylthiopropyl, 3-butylthiopropyl, 4-methylthiobutyl, 4-ethylthiobutyl, 4-propylthiobutyl, 3,6-dithiaheptyl, 3,6-dithiaoctyl,
4,8-dithianonyl, 3,7-dithiaoctyl, 3,7-dithianonyl, 2- and 4-butylthiobutyl, 4,8-dithiadecyl, 3,6,9- trithiadecyl, 3,6,9-trithiaundecyl, 3,6,9-trithiadodecyl, 3,6,9, 12-tetrathiatridecyl and 3,6,9, 12- tetrathiatetradecyl.
Examples of alkyl radicals whose carbon chains are interrupted by one or two nonadjacent het- eroatom-comprising groups -NRa- are the following:
2-monomethylaminoethyl and 2-monoethylaminoethyl, 2-dimethylaminoethyl,
3-methylaminopropyl, 2- and 3-dimethylaminopropyl, 3-monoisopropylaminopropyl, 2- and 4-monopropylaminobutyl, 2- and 4-dimethylaminobutyl, 6-methylaminohexyl,
6-dimethylaminohexyl, 6-methyl-3,6-diazaheptyl, 3,6-dimethyl-3,6-diazaheptyl, 3,6-diazaoctyl and 3,6-dimethyl-3,6-diazaoctyl. Examples of alkyl radicals whose carbon chains may be interrupted by three or more than three nonadjacent heteroatom-comprising groups - NRa - also include oligoalkylenimines and poly- alkylenimines. What has been said above with regard to the polyoxyalkylenes applies analogously to polyalkylenimines, with the oxygen atom being in each case replaced by an NRa group, where Ra is preferably hydrogen or Ci-C4-alkyl. Examples are 9-methyl-3,6,9-triazadecyl, 3,6,9-trimethyl-3,6,9-triazadecyl, 3,6,9-triazaundecyl, 3,6,9-trimethyl-3,6,9-triazaundecyl, 12- methyl-3,6,9, 12-tetraazatridecyl, 3,6,9,12-tetramethyl-3,6,9, 12-tetraazatridecyl and the like.
Examples of alkyl radicals whose carbon chains are interrupted by one or more, e.g. 1 or 2, nonadjacent -S02- groups are 2-methylsulfonylethyl, 2-ethylsulfonylethyl, 2-propylsulfonylethyl, 2-isopropylsulfonylethyl, 2-butylsulfonylethyl, 2-methylsulfonyl propyl, 3-methylsulfonylpropyl, 2- ethylsulfonyl propyl, 3-ethylsulfonylpropyl, 2-propylsulfonylpropyl, 3-propylsulfonylpropyl, 2-butylsulfonyl propyl, 3-butylsulfonylpropyl, 2-methylsulfonylbutyl, 4-methylsulfonylbutyl, 2- ethylsulfonyl butyl, 4-ethylsulfonyl butyl, 2-propylsulfonyl butyl, 4-propylsulfonylbutyl and 4- butylsulfonylbutyl.
The expression alkyl also comprises substituted alkyl radicals. Substituted alkyl groups can, depending on the length of the alkyl chain, have one or more (e.g. 1 , 2, 3, 4, 5 or more than 5) substituents. These are preferably selected independently from among cycloalkyi, cycloalkyloxy, polycyclyl, polycyclyloxy, heterocycloalkyl, aryl, aryloxy, arylthio, hetaryl, halogen, hydroxy, SH , =0, =S, =NRa, COOH, carboxylate, S03H , sulfonate, N E1 E2, nitro and cyano, where E1 and E2 are each, independently of one another, hydrogen, alkyi, cycloalkyi, heterocycloalkyl, aryl or hetaryl. Cycloalkyi, cycloalkyloxy, polycycloalkyl, polycycloalkyloxy, heterocycloalkyl, aryl and hetaryl substituents of the alkyi groups may in turn be unsubstituted or substituted; suitable substituents are those mentioned below for these groups.
What has been said above with regard to alkyi also applies in principle to the alkyi parts of alkoxy, alkylamino, dialkylamino, alkylthio (alkylsulfanyl), alkylsulfinyl, alkylsulfonyl, etc.
Suitable substituted alkyi radicals are the following: alkyi substituted by carboxy, e.g. carboxymethyl, 2-carboxyethyl, 3-carboxypropyl,
4- carboxybutyl, 5-carboxypentyl, 6-carboxyhexyl, 7-carboxyheptyl, 8-carboxyoctyl,
9-carboxynonyl, 10-carboxydecyl, 12-carboxydodecyl and 14-carboxytetradecyl;
alkyi substituted by SO3H, e.g. sulfomethyl, 2-sulfoethyl, 3-sulfopropyl, 4-sulfobutyl,
5- sulfopentyl, 6-sulfohexyl, 7-sulfoheptyl, 8-sulfooctyl, 9-sulfononyl, 10-sulfodecyl,
12-sulfododecyl and 14-sulfotetradecyl; alkyi substituted by carboxylate, for example alkoxycarbonylalkyl, e.g. methoxycarbonylmethyl, ethoxycarbonylmethyl, n-butoxycarbonylmethyl, 2-methoxycarbonylethyl, 2-ethoxycarbonylethyl,
2- methoxycarbonylpropyl, 2-ethoxycarbonylpropyl, 2-(n-butoxycarbonyl)propyl, 2-(4-n- butoxycarbonyl)propyl, 3-methoxycarbonylpropyl, 3-ethoxycarbonylpropyl, 3-(n- butoxycarbonyl)propyl, 3-(4-n-butoxycarbonyl)propyl, aminocarbonylalkyl, e.g. aminocarbonyl- methyl, aminocarbonylethyl, aminocarbonylpropyl and the like; alkylaminocarbonylalkyl such as methylaminocarbonylmethyl, methylaminocarbonylethyl, ethylcarbonylmethyl, ethylcarbonylethyl and the like, or dialkylaminocarbonylalkyl such as dimethylaminocarbonylmethyl, dimethyla- minocarbonylethyl, dimethylcarbonylpropyl, diethylaminocarbonylmethyl, diethylamino- carbonylethyl, diethylcarbonylpropyl and the like; alkyi substituted by hydroxy, e.g. 2-hydroxyethyl, 2-hydroxypropyl, 3-hydroxypropyl,
3- hydroxybutyl, 4-hydroxybutyl, 2-hydroxy-2,2-dimethylethyl, 5-hydroxy-3-oxapentyl,
6- hydroxyhexyl, 7-hydroxy-4-oxaheptyl, 8-hydroxy-4-oxaoctyl, 8-hydroxy-3,6-dioxaoctyl, 9- hydroxy-5-oxanonyl, 1 1 -hydroxy-4,8-dioxaundecyl, 1 1 -hydroxy-3,6,9-trioxaundecyl, 14-hydroxy- 5,10-dioxatetradecyl, 15-hydroxy-4,8, 12-trioxapentadecyl and the like; alkyi substituted by amino, e.g. 2-aminoethyl, 2-aminopropyl, 3-aminopropyl, 4-aminobutyl, 6- aminohexyl and the like; alkyi substituted by cyano, e.g. 2-cyanoethyl, 3-cyanopropyl, 3-cyanobutyl and 4-cyanobutyl; alkyi substituted by halogen as defined below, where the hydrogen atoms in the alkyi group may be partly or completely replaced by halogen atoms, e.g. Ci-Ci8-fluoroalkyl, e.g. trifluoromethyl, difluoromethyl, fluoromethyl, pentafluoroethyl, heptafluoropropyl, heptafluoroisopropyl, no- nafluorobutyl, nonafluoroisobutyl, undecylfluoropentyl, undecylfluoroisopentyl and the like, Ci- Ci8-chloroalkyl, e.g. chloromethyl, dichloromethyl, trichloromethyl, 2-chloroethyl, 2- and 3- chloropropyl, 2-, 3- and 4-chlorobutyl, 1 ,1 -dimethyl-2-chloroethyl and the like, C1-C18- bromoalkyl, e.g. bromoethyl, 2-bromoethyl, 2- and 3-bromopropyl and 2-, 3- and 4-bromobutyl and the like; alkyl substituted by nitro, e.g. 2-nitroethyl, 2- and 3-nitropropyl and 2-, 3- and 4-nitrobutyl and the like; alkyl substituted by cycloalkyl, e.g. cyclopentyl methyl, 2-cyclopentylethyl, 3-cyclopentylpropyl, cyclohexylmethyl, 2-cyclohexylethyl, 3-cyclohexylpropyl and the like; alkyl substituted by =0 (oxo group), e.g. 2-oxopropyl, 2-oxobutyl, 3-oxobutyl, 1 -methyl-2- oxopropyl, 2-oxopentyl, 3-oxopentyl, 1 -methyl-2-oxobutyl, 1 -methyl-3-oxobutyl, 2-oxohexyl, 3- oxohexyl, 4-oxohexyl, 2-oxoheptyl, 3-oxoheptyl, 4-oxoheptyl, 4-oxoheptyl and the like; alkyl substituted by =S (thioxo group) e.g. 2-thioxopropyl, 2-thioxobutyl, 3-thioxobutyl, 1 -methyl-
2- thioxopropyl, 2-thioxopentyl, 3-thioxopentyl, 1 -methyl-2-thioxobutyl, 1 -methyl-3-thioxobutyl, 2- thioxohexyl, 3-thioxohexyl, 4-thioxohexyl, 2-thioxoheptyl, 3-thioxoheptyl, 4-thioxoheptyl, 4- thioxoheptyl and the like; alkyl substituted by =NRa, preferably a group of the type in which Ra is hydrogen or Ci-C4-alkyl, e.g. 2-iminopropyl, 2-iminobutyl, 3-iminobutyl, 1 -methyl-2-iminopropyl, 2-iminopentyl, 3- iminopentyl, 1 -methyl-2-iminobutyl, 1 -methyl-3-imino-butyl, 2-iminohexyl, 3-iminohexyl, 4- iminohexyl, 2-iminoheptyl, 3-iminoheptyl, 4-iminoheptyl, 4-iminoheptyl, 2-methyliminopropyl, 2- methyliminobutyl, 3-methyliminobutyl, 1 -methyl-2-methyliminopropyl, 2-methyliminopentyl,
3- methyliminopentyl, 1 -methyl-2-methyliminobutyl, 1 -methyl-3-methyliminobutyl,
2-methyliminohexyl, 3-methyliminohexyl, 4-methyliminohexyl, 2-methyliminoheptyl,
3-methyliminoheptyl, 4-methyliminoheptyl, 4-methyliminoheptyl, 2-ethyliminopropyl,
2-ethyliminobutyl, 3-ethyliminobutyl, 1 -methyl-2-ethyliminopropyl, 2-ethyliminopentyl, 3- ethyliminopentyl, 1 -methyl-2-ethyliminobutyl, 1 -methyl-3-ethyliminobutyl, 2-ethyliminohexyl, 3- ethyliminohexyl, 4-ethyliminohexyl, 2-ethyliminoheptyl, 3-ethyliminoheptyl, 4-ethyliminoheptyl, 4- ethyliminoheptyl, 2-propyliminopropyl, 2-propyliminobutyl, 3-propyliminobutyl, 1 -methyl-2- propyliminopropyl, 2-propyliminopentyl, 3-propyliminopentyl, 1 -methyl-2-propyliminobutyl, 1 - methyl-3-propyliminobutyl, 2-propyliminohexyl, 3-propyliminohexyl, 4-propyliminohexyl,
2-propyliminoheptyl, 3-propyliminoheptyl, 4-propyliminoheptyl, 4-propyliminoheptyl and the like.
Alkoxy is an alkyl group bound via an oxygen atom. Examples of alkoxy are: methoxy, ethoxy, n-propoxy, 1 -methylethoxy, butoxy, 1 -methylpropoxy, 2-methylpropoxy, 1 ,1 -dimethylethoxy, n- pentoxy, 1 -methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1 ,1 -dimethylpropoxy, 1 ,2- dimethylpropoxy, 2,2-dimethylpropoxy, 1 -ethylpropoxy, hexoxy, 1 -methylpentoxy, 2- methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1 ,1 -dimethylbutoxy, 1 ,2-dimethylbutoxy, 1 ,3- dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1 -ethylbutoxy, 2-ethylbutoxy, 1 ,1 ,2-trimethylpropoxy, 1 ,2,2-trimethylpropoxy, 1 -ethyl-1 -methylpropoxy or 1 - ethyl-2-methylpropoxy, hexoxy and also RA0-(CH2CH2CH2CH20)n-CH2CH2CH2CH20- where RA is hydrogen or Ci-C4-alkyl, preferably hydrogen, methyl or ethyl, and n is from 0 to 10, preferably from 0 to 3.
Alkylthio (alkylsulfanyl) is an alkyl group bound via a sulfur atom. Examples of alkylthio are me- thylthio, ethylthio, propylthio, butylthio, pentylthio and hexylthio.
Alkylsulfinyl is an alkyl group bound via an S(=0) group. Alkylsulfonyl is an alkyl group bound via an S(=0)2 group.
Aryl-substituted alkyl radicals ("arylalkyl") have at least one unsubstituted or substituted aryl group as defined below. Suitable substituents on the aryl group are those mentioned below. The alkyl group in "arylalkyl" can bear at least one further substituent as defined above and/or be interrupted by one or more nonadjacent heteroatoms or heteroatom-comprising groups selected from among -0-, -S-, -NRa- and -S02-. Arylalkyl is preferably phenyl-C1 -C10-alkyl, particularly preferably phenyl-C1 -C4-alkyl, e.g. benzyl, 1 -phenethyl, 2-phenethyl, 1 -phenprop-1 -yl, 2- phenprop-1 -yl, 3-phenprop-1 -yl, 1 -phenbut-1 -yl, 2-phenbut-1 -yl, 3-phenbut-1 -yl, 4-phenbut-1 -yl, 1 -phenbut-2-yl, 2-phenbut-2-yl, 3-phenbut-2-yl, 4-phenbut-2-yl, 1 -(phenmeth)-eth-1 -yl,
1 - (phenmethyl)-1 -(methyl)-eth-1 -yl or -(phenmethyl)-1 -(methyl)-prop-1 -yl; preferably benzyl and
2- phenethyl.
(II) For the purposes of the present invention, the expression "alkenyl" comprises straight-chain and branched alkenyl groups which can, depending on the length oft the chain, have one or more double bonds (e.g. 1 , 2, 3, 4 or more than 4). Preference is given to C2-Cis-alkenyl, particularly preferably C2-Ci2-alkenyl groups. The expression "alkenyl" also comprises substituted alkenyl groups which may bear one or more (e.g. 1 , 2, 3, 4, 5 or more than 5) substituents. Suitable substituents are, for example, selected from among =0, =S, =NRa, cycloalkyl, cycloal- kyloxy, polycyclyl, polycyclyloxy, heterocycloalkyl, aryl, aryloxy, arylthio, hetaryl, halogen, hydroxy, SH, COOH, carboxylate, SO3H, sulfonate, alkylsulfinyl, alkylsulfonyl, NE3E4, nitro and cyano, where E3 and E4 are each, independently of one another, hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl or hetaryl.
The expression "alkenyl" also comprises alkenyl radicals whose carbon chain may be interrupted by one or more nonadjacent heteroatoms or heteroatom-comprising groups which are preferably selected from among -0-, -S-, -NRa- and -SO2-.
Alkenyl is then, for example, ethenyl (vinyl), 1 -propenyl, 2-propenyl, 1 -methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1 -pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1 -hexenyl, 2-hexenyl, 3- hexenyl, 4-hexenyl, 5-hexenyl, penta-1 ,3-dien-1 -yl, hexa-1 ,4-dien-1 -yl, hexa-1 ,4-dien-3-yl, hexa- 1 ,4-dien-6-yl, hexa-1 ,5-dien-1 -yl, hexa-1 ,5-dien-3-yl, hexa-1 ,5-dien-4-yl, hepta-1 ,4-dien-1 -yl, hepta-1 ,4-dien-3-yl, hepta-1 ,4-dien-6-yl, hepta-1 ,4-dien-7-yl, hepta-1 ,5-dien-1 -yl, hepta-1 ,5- dien-3-yl, hepta-1 ,5-dien-4-yl, hepta-1 ,5-dien-7-yl, hepta-1 ,6-dien-1 -yl, hepta-1 ,6-dien-3-yl, hep- ta-1 ,6-dien-4-yl, hepta-1 ,6-dien-5-yl, hepta-1 ,6-dien-2-yl, octa-1 ,4-dien-1 -yl, octa-1 ,4-dien-2-yl, octa-1 ,4-dien-3-yl, octa-1 ,4-dien-6-yl, octa-1 ,4-dien-7-yl, octa-1 ,5-dien-1 -yl, octa-1 ,5-dien-3-yl, octa-1 ,5-dien-4-yl, octa-1 ,5-dien-7-yl, octa-1 ,6-dien-1 -yl, octa-1 ,6-dien-3-yl, octa-1 ,6-dien-4-yl, octa-1 ,6-dien-5-yl, octa-1 ,6-dien-2-yl, deca-1 ,4-dienyl, deca-1 ,5-dienyl, deca-1 ,6-dienyl, deca- 1 ,7-dienyl, deca-1 ,8-dienyl, deca-2,5-dienyl, deca-2,6-dienyl, deca-2,7-dienyl, deca-2,8-dienyl and the like.
(III) For the purposes of the present invention, the expression "cycloalkyl" comprises both un- substituted and substituted monocyclic saturated hydrocarbon groups which generally have from 3 to 12 ring carbons, (C3-Ci2-cycloalkyl groups) such as cyclopropyl, cyclobutyl, cyclopen- tyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl or cyclododecyl, in particular C5-Ci2-cycloalkyl. Suitable substituents are generally selected from among the substituents mentioned above for alkyl groups, alkoxy and alkylthio. Substituted cycloalkyl groups can have one or more (e.g. 1 , 2, 3, 4, 5 or more than 5) substituents, and in the case of halogen the cycloalkyl radical is partially or completely substituted by halogen.
Examples of cycloalkyl groups are cyclopentyl, 2- and 3-methylcyclopentyl, 2- and
3- ethylcyclopentyl, chloropentyl, dichloropentyl, dimethylcyclopentyl, cyclohexyl, 2-, 3- and
4- methylcyclohexyl, 2-, 3- and 4-ethylcyclohexyl, 3- and 4-propylcyclohexyl, 3- and
4-isopropylcyclohexyl, 3- and 4-butylcyclohexyl, 3- and 4-sec-butylcyclohexyl, 3- and 4-tert- butylcyclohexyl, chlorohexyl, dimethylcyclohexyl, diethylcyclohexyl, methoxycyclohexyl, di- methoxycyclohexyl, diethoxycyclohexyl, butoxycyclohexyl, methylthiocyclohexyl, chlorocyclo- hexyl, dichlorocyclohexyl, cycloheptyl, 2-, 3- and 4-methylcycloheptyl, 2-, 3- and
4-ethylcycloheptyl, 3- and 4-propylcycloheptyl, 3- and 4-isopropylcycloheptyl, 3- and
4-butylcycloheptyl, 3- and 4-sec-butylcycloheptyl, 3- and 4-tert-butylcycloheptyl, cyclooctyl, 2-, 3-, 4- and 5-methylcyclooctyl, 2-, 3-, 4- and 5-ethylcyclooctyl, 3-, 4- and 5-propylcyclooctyl, partially fluorinated cycloalkyl and perfluorinated cycloalkyl of the formula CnF2(n-a)-(i-b)H2a-b where n = 5 to 12, 0 <= a <= n and b = 0 or 1.
Cycloalkyloxy is a cycloalkyl group as defined above bound via oxygen.
(IV) The expression "cycloalkenyl" comprises unsubstituted and substituted, singly or doubly unsaturated hydrocarbon groups having from 3 to 5, up to 8, up to 12, preferably from 5 to 12, ring carbons, e.g. cyclopent-1 -en-1 -yl, cyclopent-2-en-1 -yl, cyclopent-3-en-1 -yl, cyclohex-1 -en- 1 -yl, cyclohex-2-en-1 -yl, cyclohex-3-en-1 -yl, cyclohexa-2,5-dien-1 -yl and the like. Suitable sub- stituents are those mentioned above for cycloalkyl.
Cycloalkenyloxy is a cycloalkenyl group as defined above bound via oxygen. (V) For the purposes of the present invention, the expression "polycyclyl" comprises in the broadest sense compounds which comprise at least two rings, regardless of how these rings are linked. These can be carbocyclic and/or heterocyclic rings. The rings can be saturated or unsaturated. The rings can be linked via a single or double bond ("multiring compounds") joined by fusion ("fused ring systems") or bridged ("bridged ring systems", "cage compounds"). Preferred polycyclic compounds are bridged ring systems and fused ring systems. Fused ring systems can be aromatic, hydroaromatic and cyclic compounds joined by fusion (fused compounds). Fused ring systems comprise two, three or more than three rings. Depending on the way in which the rings are joined in fused ring systems, a distinction is made between ortho- fusion, i.e. each ring shares an edge or two atoms with each adjacent ring, and peri-fusion in which a carbon atom belongs to more than two rings. Among fused ring systems, preference is given to ortho-fused ring systems. For the purposes of the present invention, bridged ring systems include systems which do not belong to the multiring ring systems nor to the fused ring systems and in which at least two ring atoms belong to at least two different rings. Among the bridged ring systems, a distinction is made according to the number of ring opening reactions which are formally required to obtain an open-chain compound between bicyclo, tricyclo, tetra- cyclo compounds, etc., which comprise two, three, four, etc., rings. The expression "bicycloal- kyl" comprises bicyclic hydrocarbon radicals which preferably have from 5 to 10 carbon atoms, e.g. bicyclo[2.2.1 ]hept-1 -yl, bicyclo[2.2.1 ]hept-2-yl, bicyclo[2.2.1 ]hept-7-yl, bicyclo[2.2.2]oct-1 -yl, bicyclo[2.2.2]oct-2-yl, bicyclo[3.3.0]octyl, bicyclo[4.4.0]decyl and the like. The expression "bicy- cloalkenyl" comprises monounsaturated, bicyclic hydrocarbon radicals which preferably have from 5 to 10 carbon atoms, e.g. bicyclo[2.2.1 ]hept-2-en-1 -yl.
(VI) For the purposes of the present invention, the expression "aryl" comprises aromatic hydro- carbon radicals which have one or more rings and may be unsubstituted or substituted. The term aryl generally refers to hydrocarbon radicals having from 6 to 10, up to 14, up to 18, preferably from 6 to 10, ring carbons. Aryl is preferably unsubstituted or substituted phenyl, naph- thyl, anthracenyl, phenanthrenyl, naphthacenyl, chrysenyl, pyrenyl, etc., and particularly preferably phenyl or naphthyl. Substituted aryls can, depending on the number and size of their ring systems, have one or more (e.g. 1 , 2, 3, 4, 5 or more than 5) substituents. These are preferably selected independently from among alkyl, alkoxy, cycloalkyl, cycloalkyloxy, heterocycloalkyl, aryl, aryloxy, arylthio, hetaryl, halogen, hydroxy, SH, alkylthio, alkylsulfinyl, alkylsulfonyl, COOH, carboxylate, SO3H, sulfonate, NE5E6, nitro and cyano, where E5 and E6 are each, independently of one another, hydrogen, alkyl, cycloalkyl, cycloalkyloxy, polycyclyl, polycyclyloxy, heterocyclo- alkyl, aryl, aryloxy or hetaryl. Aryl is particularly preferably phenyl which, if it is substituted, can generally bear 1 , 2, 3, 4 or 5 substituents, preferably 1 , 2 or 3 substituents.
Aryl which bears one or more radicals is, for example, 2-, 3- and 4-methylphenyl, 2,4-, 2,5-, 3,5- and 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2-, 3- and 4-ethylphenyl, 2,4-, 2,5-, 3,5- and 2,6- diethylphenyl, 2,4,6-triethylphenyl, 2-, 3- and 4-propylphenyl, 2,4-, 2,5-, 3,5- and 2,6- dipropylphenyl, 2,4,6-tripropylphenyl, 2-, 3- and 4-isopropylphenyl, 2,4-, 2,5-, 3,5- and
2,6-diisopropylphenyl, 2,4,6-triisopropylphenyl, 2-, 3- and 4-butylphenyl, 2,4-, 2,5-, 3,5- and 2,6-dibutylphenyl, 2,4,6-tributylphenyl, 2-, 3- and 4-isobutylphenyl, 2,4-, 2,5-, 3,5- and 2,6- diisobutylphenyl, 2,4,6-triisobutylphenyl, 2-, 3- and 4-sec-butylphenyl, 2,4-, 2,5-, 3,5- and 2,6-di- sec-butylphenyl, 2,4,6-tri-sec-butylphenyl, 2-, 3- and 4-tert-butylphenyl, 2,4-, 2,5-, 3,5- and 2,6- di-tert-butylphenyl, 2,4,6-tri-tert-butylphenyl and 2-, 3-, 4-dodecylphenyl; 2-, 3- and 4- methoxyphenyl, 2,4-, 2,5-, 3,5- and 2,6-dimethoxyphenyl, 2,4,6-trimethoxyphenyl, 2-, 3- and 4-ethoxyphenyl, 2,4-, 2,5-, 3,5- and 2,6-diethoxyphenyl, 2,4,6-triethoxyphenyl, 2-, 3- and 4- propoxyphenyl, 2,4-, 2,5-, 3,5- and 2,6-dipropoxyphenyl, 2-, 3- and 4-isopropoxyphenyl, 2,4-, 2,5-, 3,5- and 2,6-diisopropoxyphenyl, 2-, 3- and 4-butoxyphenyl, 2-, 3-, 4-hexyloxyphenyl; 2-, 3- , 4-chlorophenyl, 2,4-, 2,5-, 3,5- and 2,6-dichlorophenyl, trichlorophenyl, 2-, 3-, 4-fluorophenyl, 2,4-, 2,5-, 3,5- and 2,6-difluorophenyl, trifluorophenyl, for example 2,4,6-trifluorophenyl, tetra- fluorophenyl, pentafluorophenyl, 2-, 3- and 4-cyanophenyl; 2-nitrophenyl, 4-nitrophenyl, 2,4-dinitrophenyl, 2,6-dinitrophenyl; 4-dimethylaminophenyl; 4-acetylphenyl; methoxyeth- ylphenyl, ethoxymethylphenyl; methylthiophenyl, isopropylthiophenyl or tert-butylthiophenyl; methylnaphthyl; isopropylnaphthyl or ethoxynaphthyl. Examples of substituted aryl in which two substituents bound to adjacent carbon atoms of the aryl ring form a fused ring or fused ring system are indenyl and fluorenyl.
For the purposes of the present invention, the expression "aryloxy" refers to aryl bound via an oxygen atom.
For the purposes of the present invention, the expression "arylthio" refers to aryl bound via a sulfur atom.
(VII) For the purposes of the present invention, the expression "heterocycloalkyl" comprises nonaromatic, unsaturated or fully saturated, cycloaliphatic groups which generally have from 5 to 8 ring atoms, for example 5 or 6 ring atoms, and in which 1 , 2 or 3 of the ring carbons have been replaced by heteroatoms selected from among oxygen, nitrogen, sulfur and an -NRa- group and which are unsubstituted or substituted by one or more, for example, 1 , 2, 3, 4, 5 or 6, Ci-C6-alkyl groups. Examples of such heterocycloaliphatic groups are pyrrolidinyl, piperidinyl, 2,2,6,6-tetramethylpiperidinyl, imidazolidinyl, pyrazolidinyl, oxazolidinyl, morpholidinyl, thiazoli- dinyl, isothiazolidinyl, isoxazolidinyl, piperazinyl, tetrahydrothienyl, dihydrothienyl, tetrahydro- furanyl, dihydrofuranyl, tetrahydropyranyl, 1 ,2-oxazolin-5-yl, 1 ,3-oxazolin-2-yl and dioxanyl. Nitrogen-comprising heterocycloalkyl can in principle be bound either via a carbon atom or via a nitrogen atom.
(VIII) For the purposes of the present invention, the expression "heteroaryl (hetaryl)" comprises unsubstituted or substituted, heteroaromatic groups which have one or more rings and generally have from 5 to 14 ring atoms, preferably 5 or 6 ring atoms, in which 1 , 2 or 3 of the ring carbons have been replaced by one, two, three or four heteroatoms selected from among O, N, -NRa- and S, e.g. furyl, thienyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, benzofuranyl, benzthiazolyl, benzimidazolyl, pyridyl, quinolinyl, acridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrrolyl, imidazol- yl, pyrazolyl, indolyl, purinyl, indazolyl, benzotriazolyl, 1 ,2,3-triazolyl, 1 ,3,4-triazolyl and carba- zolyl, where these heterocycloaromatic groups may, if they are substituted, generally bear 1 , 2 or 3 substituents. The substituents are generally selected from among Ci-C6-alkyl, Ci-C6-alkoxy, hydroxy, carboxy, halogen and cyano. 5- to 7-membered nitrogen-comprising heterocycloalkyl or heteroaryl radicals which may optionally comprise further heteroatoms are, for example, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, pyrrolidinyl, pyrazolinyl, pyrazolidinyl, imidazolinyl, imidazolidinyl, pyridinyl, pyridazinyl, pyrimidi- nyl, pyrazinyl, triazinyl, piperidinyl, piperazinyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, indolyl, quinolinyl, isoquinolinyl or quinaldinyl which may be unsubstituted or substituted as mentioned above.
(IX) For the purposes of the present invention, carboxylate and sulfonate are preferably a derivative of a carboxylic acid function or a sulfonic acid function, in particular a metal carboxylate or sulfonate, a carboxylic ester or sulfonic ester function or a carboxamide or sulfonamide function. These include, for example, esters with Ci-C4-alkanols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol and tert-butanol.
(X) For the purposes of the present invention, the expression "acyl" refers to alkanoyl, hetaroyl or aroyl groups which generally have from 1 to 1 1 , preferably from 2 to 8, carbon atoms, for ex- ample the formyl, acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, 2-ethylhexanoyl, 2-propylheptanoyl, benzoyl or naphthoyl group.
Halogen is fluorine, chlorine, bromine or iodine herein. Suitable monosubstituted oxalic acid derivatives of the general formula (I) have a molar mass of less than 1000 g/mol, preferably less than 600 g/mol and in particular less than 400 g/mol.
The meaning of the substituents and terms in formula (I) is the following: [A]+ is a cation made from an organic moiety A having a formally positively charged heteroatom selected from the group consisting of nitrogen, phosphorus and sulfur, preferably from nitrogen and phosphorus. The organic moiety which contains the formally positively charged heteroatom can be linear or cyclic. The organic moiety which contains a nitrogen atom as formally positively charged heteroatom is preferably cyclic and does for example include the respective com- pounds mentioned under the groups (VII) and (VIII) above. The organic moiety which contains a nitrogen atom as formally positively charged heteroatom is more preferably a five-membered heterocycle having one formally positively charged nitrogen atom and may further contain one or more other heteroatoms which are not formally positively charged. Notwithstanding the foregoing the following compounds are disclaimed as compounds (I) as such, however not their use as described below is disclaimed:
Tetramethylammonium monomethyloxalate
Methyltri(alkyl)ammonium monomethyloxalate
Trimethyl(1 -hydroxyethyl)ammonium monomethyloxalate
Methyltriethylammonium monomethyloxalate
Tetraethylammonium monomethyloxalate
n-Propyltriethylammonium mono-n-propyloxalate
n-Butyltriethylammonium mono-n-butyloxalate
Benzyltriethylammonium monobenzyloxalate
cyclohexyldimethylammonium monomethyloxalate
Dimethyl-phenylammonium monomethyloxalate.
Tetrabutylammonium monomethyloxalate
N-methylpyridinium monomethyloxalate
N-ethylpyridinium monoethyloxalate
N-n-propylpyridinium mono-n-propyloxalate
N-n-butylpyridinium mono-n-butyl-oxalate
N-benzylpyridinium monobenzyloxalate
N-methyl-isochinolinium monomethyloxalate
N-ethyl-isochinolinium monoethyloxalate
N-n-propyl-isochinolinium mono-n-propyloxalate
N-n-butyl-isochinolinium mono-n-butyloxalate
N-benzyl-isochinolinium monobenzyloxalate
Preferably [A]+ is selected from among the compounds of the formulae (IV. a) to (IV.z), however not including [A]+ of the above disclaimed compounds to the extent they relate to the composition of matter claims:
Figure imgf000013_0001
(IV.a) (IV.b) (IV.c)
Figure imgf000013_0002
(IV.d) (IV.e) (IV.f)
Figure imgf000014_0001
Figure imgf000014_0002
(IV.i) (IV.j) (IV.j')
Figure imgf000014_0003
(IV.k) (IV.k') (IV.I)
Figure imgf000014_0004
(IV.m) (IV.m') (IV.n)
Figure imgf000014_0005
(IV.n') (IV.o) (IV.o')
Figure imgf000014_0006
(IV.p) (IV.q) (IV.q')
Figure imgf000015_0001
(IV.r") (IV.s) (IV.t)
Figure imgf000015_0002
(IV.u) (IV.v) (IV.w)
Figure imgf000015_0003
(IV.x.1) (IV.x.2)
Figure imgf000015_0004
(IV.y) (IV.z) and oligomers comprising these structures, where
R is a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under groups (I) to (VIII) above, for example substituted or unsubstituted "alkyl", "arylalkyl", "alkenyl", "cycloalkyl", "cycloalkenyl", "polycyclyl", "aryl", "ar- yloxy", "arylthio", "heterocycloalkyl","heteroarayl", very preferably a straight chain or branched C1 to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl" residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl; radicals R1, R2, R3, R4, R5, R6, R7, R8 and R9 which are bound to a ring carbon are each, independently of one another, hydrogen, a sulfo group, COOH, carboxylate, sulfonate, acyl, alkoxycarbonyl, cyano, halogen, hydroxyl, SH, nitro, NE1E2, alkyl, alkoxy, alkylthio, alkyl- sulfinyl, alkylsulfonyl, alkenyl, cycloalkyl, cycloalkyloxy, cycloalkenyl, cycloalkenyloxy, pol- ycyclyl, polycyclyloxy, heterocycloalkyi, aryl, aryloxy or heteroaryl, where E1 and E2 are each, independently of one another, hydrogen, alkyl, cycloalkyl, heterocycloalkyi, aryl or hetaryl, radicals R1, R2, R3, R4, R5, R6, R7, R8 and R9 which are bound to a ring heteroatom are each hydrogen, SO3H, NE1E2, alkyl, alkoxy, alkenyl, cycloalkyl, cycloalkenyl, polycydyl, heterocycloalkyi, aryl or heteroaryl, where E1 and E2 are each, independently of one another, hydrogen, alkyl, cycloalkyl, heterocycloalkyi, aryl or hetaryl, or two adjacent radicals R1 to R9 together with the ring atoms to which they are bound may also form at least one fused-on, saturated, unsaturated or aromatic ring or a ring system having from 1 to 30 carbon atoms, where the ring or the ring system may have from 1 to 5 nonadjacent heteroatoms or heteroatom-comprising groups and the ring or the ring system may be unsubstituted or substituted, two geminal radicals R1 to R9 may also together be =0, =S or =NRb, where Rb is hydrogen, alkyl, cycloalkyl, aryl or heteroaryl, and R1 and R3 or R3 and R5 in the compounds of the formula (IV.x.1 ) may together also represent the second part of a double bond between the ring atoms bearing these radicals,
B in the compounds of the formulae (IV.x.1 ) and (IV.x.2) together with the C-N group to which it is bound forms a 4- to 8-membered, saturated or unsaturated or aromatic ring which may optionally be substituted and/or may optionally have further heteroatoms or heteroatom-comprising groups and/or may comprise further fused-on, saturated, unsaturated or aromatic carbocycles or heterocycles.
As regards the general meaning of the abovementioned radicals carboxylate, sulfonate, acyl, alkoxycarbonyl, halogen, NE1E2, alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkenyl, cy- cloalkyi, cycloalkyloxy, cycloalkenyl, cycloalkenyloxy, polycydyl, polycyclyloxy, heterocycloalkyi, aryl, aryloxy or heteroaryl, what has been said above applies in full. Radicals R1 to R9 in the abovementioned formulae (IV) which are bound to a carbon atom and have a heteroatom or a heteroatom-comprising group can also be bound directly via a heteroatom to the carbon atom. If two adjacent radicals R1 to R9 together with the ring atoms to which they are bound form at least one fused-on, saturated, unsaturated or aromatic ring or a ring system having from 1 to 30 carbon atoms, where the ring or ring system can have from 1 to 5 nonadjacent heteroatoms or heteroatom-comprising groups and the ring or the ring system may be unsubstituted or substituted, these radicals can together as fused-on building blocks preferably be 1 ,3-propylene, 1 ,4- butylene, 1 ,5-pentylene, 2-oxa-1 ,3-propylene, 1 -oxa-1 ,3-propylene, 2-oxa-1 ,3-propylene, 1 -oxa- 1 ,3-propenylene, 3-oxa-1 ,5-pentylene, 1 -aza-1 ,3-propenylene, 1 -Ci-C4-alkyl-1 -aza-1 ,3- propenylene, 1 ,4-buta-1 ,3-dienylene, 1 -aza-1 ,4-buta-1 ,3-dienylene or 2-aza-1 ,4-buta-1 ,3- dienylene.
The radical R is for example - unsubstituted Ci-Cis-alkyl such as methyl, ethyl, 1 -propyl, 2-propyl, 1 -butyl, 2-butyl, 2- methyl-1 -propyl (isobutyl), 2-methyl-2-propyl (tert-butyl), 1 -pentyl, 2-pentyl, 3-pentyl, 2- methyl-1 -butyl, 3-methyl-1 -butyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 2,2-dimethyl-1 -propyl, 1 -hexyl, 2-hexyl, 3-hexyl, 2-methyl-1 -pentyl, 3-methyl-1 -pentyl, 4-methyl-1 -pentyl, 2- methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3-methyl-3- pentyl, 2,2-dimethyl-1 -butyl, 2,3-dimethyl-1 -butyl, 3,3-dimethyl-1 -butyl, 2-ethyl-1 -butyl, 2,3- dimethyl-2-butyl, 3,3-dimethyl-2-butyl, 1 -heptyl, 1 -octyl, 1 -nonyl, 1 -decyl, 1 -undecyl, 1 - dodecyl, 1 -tetradecyl, 1 -hexadecyl and 1 -octadecyl;
Ci-Cis-alkyl substituted by one or more hydroxy, halogen, phenyl, cyano, C1-C6- alkoxycarbonyl and/or SO3H groups, especially hydroxy-Ci-Ci8-alkyl such as
2-hydroxyethyl or 6-hydroxyhexyl; phenyl-Ci-Cis-alkyl, such as benzyl, 3-phenylpropyl; cyano-Ci-Cis-alkyl, such as 2-cyanoethyl; Ci-C6-alkoxy-Ci-Ci8-alkyl, such as 2- (methoxycarbonyl)ethyl, 2-(ethoxycarbonyl)ethyl or 2-(n-butoxycarbonyl)ethyl; C1-C18- fluoroalkyl such as trifluoromethyl, difluoromethyl, fluoromethyl, pentafluoroethyl, hep- tafluoropropyl, heptafluoroisopropyl, nonafluorobutyl, nonafluoroisobutyl, undecylfluoro- pentyl, undecylfluoroisopentyl; sulfo-Ci-Ci8-alkyl such as 3-sulfopropyl;
hydroxyethyloxyalkyl, radicals of oligoalkylene and polyalkylene glycols such as polyethylene glycols and polypropylene glycols and their oligomers having 2 to 100 units and a hydrogen or a Ci-Cs-alkyl as end group, for example
RA0-(CHRB-CH2-0)n-CHRB-CH2- where RA and RB are preferably each hydrogen, methyl or ethyl and n is preferably from 0 to 3, in particular 3-oxabutyl, 3-oxapentyl, 3,6- dioxaheptyl, 3,6-dioxaoctyl, 3,6,9-trioxadecyl, 3,6,9-trioxaundecyl, 3,6,9,12- tetraoxatridecyl and 3,6,9,12-tetraoxatetradecyl; and
C2-C6-alkenyl such as vinyl or propenyl.
Preference is given to the radicals R1 to R9 each being, independently of one another, hydrogen;
halogen;
- a functional group selected from among hydroxy, alkoxy, alkylthio, carboxyl, -COOH, sulfonate, cyano, acyl, alkoxycarbonyl, NE1E2 and nitro, where E1 and E2 are as defined above; Ci-Ci8-alkyl which is unsubstituted or substituted as defined above and/or may, as defined above, be interrupted by at least one heteroatom or heteroatom-comprising group;
C2-Ci8-alkenyl which is unsubstituted or substituted as defined above and/or may, as defined above, be interrupted by at least one heteroatom;
- C6-Cio-aryl which is unsubstituted or substituted as defined above;
C5-Ci2-cycloalkyl which is unsubstituted or substituted as defined above;
polycyclyl which is unsubstituted or substituted as defined above;
C5-Ci2-cycloalkenyl which is unsubstituted or substituted as defined above;
heterocycloalkyi having 5 or 6 ring atoms, where the ring comprises, apart from ring car- bons, 1 , 2 or 3 heteroatoms or heteroatom-comprising groups selected from among oxygen, nitrogen, sulfur and NRa and is unsubstituted or substituted as defined above;
heteroaryl having from 5 to 10 ring atoms, where the ring has, apart from ring carbons, 1 , 2 or 3 heteroatoms or heteroatom-comprising groups selected from among oxygen, nitrogen, sulfur and NRa and is unsubstituted or substituted as defined above.
Preference is likewise given to two adjacent radicals R1 to R9 together with the ring atoms to which they are bound forming at least one fused-on, saturated, unsaturated or aromatic ring or ring system having from 1 to 12 carbon atoms, where the ring or ring system may have from 1 to 5 nonadjacent heteroatoms or heteroatom-comprising groups which are preferably selected from among oxygen, nitrogen, sulfur and NRa and the ring or the ring system may be unsubstituted or substituted, where the substituents are preferably selected independently from among alkoxy, cycloalkyi, cycloalkoxy, polycyclyl, polycyclyloxy, heterocycloalkyi, aryl, aryloxy, arylthio, heteroaryl halogen, hydroxy, SH, =0, =S, =NRa, COOH, carboxylate, -S03H, sulfonate, NE1E2, nitro and cyano, where E1 and E2 are each, independently of one another, hydrogen, alkyl, cy- cloalkyl, heterocycloalkyi, aryl or hetaryl.
If R1 to R9 are alkoxy, then R1 to R9 are preferably methoxy or ethoxy or
RA0-(CH2CH2CH2CH20)n-CH2CH2CH2CH20- where RA and RB are preferably each hydrogen, methyl or ethyl and n is preferably from 0 to 3.
If R1 to R9 are acyl, then R1 to R9 are preferably formyl or Ci-C4-alkylcarbonyl, in particular formyl or acetyl.
If R1 to R9 are Ci-Cis-alkyl, then R1 to R9 are preferably unsubstituted Ci-Cis-alkyl such as me- thyl, ethyl, 1 -propyl, 2-propyl, 1 -butyl, 2-butyl, 2-methyl-1 -propyl (isobutyl), 2-methyl-2-propyl (tert-butyl), 1 -pentyl, 2-pentyl, 3-pentyl, 2-methyl-9-butyl, 3-methyl-1 -butyl, 2-methyl-2-butyl, 3- methyl-2-butyl, 2, 2-dimethyl-1 -propyl, 1 -hexyl, 2-hexyl, 3-hexyl, 2-methyl-1 -pentyl, 3-methyl-1 - pentyl, 4-methyl-1 -pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3- pentyl, 3-methyl-3-pentyl, 2,2-dimethyl-1 -butyl, 2,3-dimethyl-1 -butyl, 3,3-dimethyl-1 -butyl, 2- ethyl-1 -butyl, 2,3-dimethyl-2-butyl, 3,3-dimethyl-2-butyl, heptyl, octyl, 2-ethylhexyl, 2,4,4- trimethyl-pentyl, 1 ,1 ,3,3-tetramethylbutyl, 1 -nonyl, 1 -decyl, 1 -undecyl, 1 -dodecyl, 1 -tridecyl, 1 -tetradecyl, 1 -pentadecyl, 1 -hexadecyl, 1 -heptadecyl, 1 -octadecyl; Ci-Ci8-haloalkyl, especially Ci-Ci8-fluoroalkyl, for example trifluoromethyl, difluoromethyl, fluoro- methyl, pentafluoroethyl, heptafluoropropyl, heptafluoroisopropyl, nonafluorobutyl, no- nafluoroisobutyl, undecylfluoropentyl, undecylisopentyl, C6F13, CsFi7, C10F21, C12F25, especially Ci-Ci8-chloroalkyl such as chloromethyl, 2-chloroethyl, trichloromethyl, 1 ,1 -dimethyl-2- chloroethyl; amino-Ci-Ci8-alkyl such as 2-aminoethyl, 2-aminopropyl, 3-aminopropyl, 4-aminobutyl, 6- aminohexyl, Ci-C6-alkylamino-Ci-Ci8-alkyl such as 2-methylaminoethyl, 2-methylaminopropyl,
3-methylaminopropyl, 4-methylaminobutyl, 6-methylaminohexyl; di(Ci-C6-alkyl)-Ci-Ci8-alkyl such as 2-dimethylaminoethyl, 2-dimethylaminopropyl,
3-dimethylaminopropyl, 4-dimethylaminobutyl, 6-dimethylaminohexyl, cyano-Ci-Ci8-alkyl such as 2-cyanoethyl, 2-cyanopropyl,
Ci-Cio-alkoxy-Ci-Ci8-alkyl such as methoxymethyl, 2-methoxyethyl, 2-methoxypropyl,
3-methoxypropyl, 2-methoxyisopropyl, 4-methoxybutyl, 6-methoxyhexyl, 2-ethoxyethyl, 2- ethoxypropyl, 3-ethoxypropyl, 4-ethoxybutyl, 6-ethoxyhexyl, 2-isopropoxyethyl, 2-butoxyethyl, 2- butoxypropyl, 2-octyloxyethyl, 5-methoxy-3-oxa-pentyl, 8-methoxy-3,6-dioxaoctyl, 7-methoxy-4- oxaheptyl, 1 1 -methoxy-4,8-dioxaundecyl, 9-methoxy-5-oxanonyl, 9-methoxy-5-oxanonyl, 14- methoxy-5,10-dioxatetradecyl, 5-ethoxy-3-oxapentyl, 8-ethoxy-3,6-dioxaoctyl, 7-ethoxy-4- oxaheptyl, 1 1 -ethoxy-4,8-dioxaundecyl, 9-ethoxy-5-oxanonyl or 14-ethoxy-5,10-oxatetradecyl, 15-methoxy-4,8,12-trioxapentadecyl, 1 1 -methoxy-3,6,9-trioxaundecyl, 1 1 -ethoxy-3,6,9- trioxaundecyl, 15-ethoxy-4,8,12-trioxapentadecyl; di(Ci-Cio-alkoxy-Ci-Ci8-alkyl) such as diethoxymethyl or diethoxyethyl, Ci-C6-alkoxycarbonyl-Ci-Ci8-alkyl such as 2-(methoxycarbonyl)ethyl, 2-(ethoxycarbonyl)ethyl, 2-(n-butoxycarbonyl)ethyl, di(Ci-C6-alkoxycarbonyl)-Ci-Ci8-alkyl such as 1 ,2-di(methoxycarbonyl)ethyl, hydroxy-Ci-Ci8-alkyl such as 2-hydroxyethyl, 2-hydroxypropyl, 3-hydroxypropyl, 4-hydroxybutyl, 6-hydroxyhexyl, 2-hydroxy-2,2-dimethylethyl, 5-hydroxy-3-oxapentyl, 8-hydroxy-3,6-dioxaoctyl, 1 1 -hydroxy-3,6,9-trioxaundecyl, 7-hydroxy-4-oxaheptyl, 1 1 -hydroxy-4,8-dioxaundecyl, 15- hydroxy-4,8,12-trioxapentadecyl, 9-hydroxy-5-oxanonyl, 14-hydroxy-5,10-dioxatetradecyl;
Ci-Ci2-alkylsulfanyl-Ci-Ci8-alkyl such as butylthiomethyl, 2-dodecylthioethyl, C5-Ci2-cycloalkyl-Ci-Ci8-alkyl such as cyclopentylmethyl, 2-cyclopentylethyl,
3- cyclopentylpropyl, cyclohexylmethyl, 2-cyclohexylethyl, 3-cyclohexylpropyl,
phenyl-Ci-Cis-alkyl, where the phenyl part of phenyl-Ci-Cis-alkyl is unsubstituted or substituted by one, two, three or four substituents selected independently from among Ci-C6-alkyl, halogen, Ci-C6-alkoxy and nitro, e.g. benzyl (phenylmethyl), 1 -phenylethyl, 2-phenylethyl, 3-phenylpropyl, p-tolylmethyl, 1 -(p-butylphenyl)ethyl, p-chlorobenzyl, 2,4-dichlorobenzyl, p-methoxybenzyl, m-ethoxybenzyl, phenyl-C(CH3)2-, 2,6-dimethylphenylmethyl, diphenyl-Ci-Ci8-alkyl such as diphenylmethyl (benzhydryl); triphenyl-Ci-Ci8-alkyl such as triphenylmethyl; phenoxy-Ci-Ci8-alkyl such as 2-phenoxyethyl, 2-phenoxypropyl, 3-phenoxypropyl,
4- phenoxybutyl, 6-phenoxyhexyl; phenylthio-Ci-Ci8-alkyl such as 2-phenylthioethyl.
If R1 to R9 are C2-Cis-alkenyl, then R1 to R9 are preferably each C2-C6-alkenyl such as vinyl, 2- propenyl, 3-butenyl, cis-2-butenyl, trans-2-butenyl or C2-Cis-alkenyl which may be partially or completely substituted by fluorine.
If R1 to R9 are C6-Cio-aryl, then R1 to R9 are each preferably phenyl or naphthyl, where phenyl or naphthyl is unsubstituted or substituted by one, two, three or four substituents selected independently from among halogen, Ci-Cis-alkyl, Ci-C6-alkoxy, Ci-C6-alkylsulfanyl, Ci-C6-alkoxy-Ci- C6-alkyl, Ci-C6-alkylcarbonyl, amino, Ci-C6-alkylamino, di(Ci-C6-dialkyl)amino and nitro, e.g. phenyl, methylphenyl (tolyl), dimethylphenyl (xylyl) such as 2,6-dimethylphenyl, trimethylphenyl such as 2,4,6-trimethylphenyl, ethylphenyl, diethylphenyl, isopropylphenyl, tert-butylphenyl, do- decylphenyl, chlorophenyl, dichlorophenyl, trichlorophenyl, fluorophenyl, difluorophenyl, trifluor- ophenyl, tetrafluorophenyl, pentafluorophenyl, 2,6-dichlorophenyl, 4-bromophenyl, methoxy- phenyl, dimethoxyphenyl, ethoxyphenyl, hexyloxyphenyl, 2,6-dimethoxyphenyl, 2-nitrophenyl, 4-nitrophenyl, 2,4-dinitrophenyl, 2,6-dinitrophenyl, 4-dimethylaminophenyl, 4-acetylphenyl, methoxyethylphenyl, ethoxymethylphenyl, methylthiophenyl, isopropylthiophenyl, tert- butylthiophenyl, a-naphthyl, β-naphthyl, methylnaphthyl, isopropylnaphthyl, chloronaphthyl, ethoxynaphthyl or partially fluorinated phenyl or perfluorinated phenyl.
If R1 to R9 are C5-Ci2-cycloalkyl, then R1 to R9 are preferably each unsubstituted cycloalkyl such as cyclopentyl or cyclohexyl;
C5-Ci2-cycloalkyl which is substituted by one or two substituents selected independently from among Ci-C6-alkyl, Ci-C6-alkoxy, Ci-C6-alkylsulfanyl and chlorine, e.g. butylcyclohexyl, methox- ycyclohexyl, dimethoxycyclohexyl, diethoxycyclohexyl, butylthiocyclohexyl, chlorocyclohexyl, dichlorocyclohexyl, dichlorocyclopentyl; C5-Ci2-cycloalkyl which is completely or fully fluorinated.
If R1 to R9 are polycyclyl, then R1 to R9 are each preferably C5-Ci2-bicycloalkyl such as nor- bornyl or C5-Ci2-bicycloalkenyl such as norbornenyl.
If R1 to R9 are C5-Ci2-cycloalkenyl, then R1 to R9 are each preferably unsubstituted cycloal- kenyl such as cyclopent-2-en-1 -yl, cyclopent-3-en-1 -yl, cyclohex-2-en-1 -yl, cyclohex-1 -en-1 -yl, cyclohexa-2,5-dien-1 -yl or partially or completely fluorinated cycloalkenyl. If R1 to R9 are heterocycloalkyl having 5 or 6 ring atoms, then R1 to R9 are each preferably 1 ,3- dioxolan-2-yl, 1 ,3-dioxan-2-yl, 2-methyl-1 ,3-dioxolan-2-yl, 4-methyl-1 ,3-dioxolan-2-yl.
If R1 to R9 are heteroaryl, then R1 to R9 are each preferably furyl, thienyl, pyrryl, pyridyl, indolyl, benzoxazolyl, benzimidazolyl, benzothiazolyl. If hetaryl is substituted, it bears 1 , 2 or 3 substitu- ents selected independently from among Ci-C6-alkyl, Ci-C6-alkoxy and halogen, for example dimethylpyridyl, methylquinolyl, dimethylpyrryl, methoxyfuryl, dimethoxypyridyl or difluoropyridyl.
Particular preference is given to the radicals R1 to R9 each being, independently of one another, - hydrogen;
unbranched or branched Ci-Cis-alkyl which may be unsubstituted or substituted by one or more hydroxy, halogen, phenyl, cyano, Ci-C6-alkoxycarbonyl and/or sulfo groups, for example methyl, ethyl, 1 -propyl, 2-propyl, 1 -butyl, 2-butyl, 2-methyl-1 -propyl (isobutyl), 2- methyl-2-propyl (tert-butyl), 1 -pentyl, 2-pentyl, 3-pentyl, 2-methyl-1 -butyl, 3-methyl-1 -butyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 2,2-dimethyl-1 -propyl, 1 -hexyl, 2-hexyl, 3-hexyl, 2- methyl-1 -pentyl, 3-methyl-1 -pentyl, 4-methyl-1 -pentyl, 2-methyl-2-pentyl, 3-methyl-2- pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3-methyl-3-pentyl, 2,2-dimethyl-1 -butyl, 2,3-dimethyl-1 -butyl, 3,3-dimethyl-1 -butyl, 2-ethyl-1 -butyl, 2,3-dimethyl-2-butyl,
3,3-dimethyl-2-butyl, 1 -heptyl, 1 -octyl, 1 -nonyl, 1 -decyl, 1 -undecyl, 1 -dodecyl, 1 -tetradecyl, 1 -hexadecyl, 1 -octadecyl, 2-hydroxyethyl, benzyl, 3-phenylpropyl, 2-cyanoethyl, methox- ycarbonylmethyl, ethoxycarbonylmethyl, n-butoxycarbonylmethyl, tert-butoxy- carbonylmethyl, 2-(methoxycarbonyl)ethyl, 2-(ethoxycarbonyl)ethyl,
2-(n-butoxycarbonyl)ethyl, trifluoromethyl, difluoromethyl, fluoromethyl, pentafluoroethyl, heptafluoropropyl, heptafluoroisopropyl, nonafluorobutyl, nonafluoroisobutyl, un- decylfluoropentyl, undecylfluoroisopentyl, 6-hydroxyhexyl and 3-sulfopropyl;
hydroxyethyloxyalkyl, radicals of oligoalkylene and polyalkylene glycols such as polyethylene glycols and polypropylene glycols and their oligomers having from 2 to 100 units and a hydrogen or a Ci-Cs-alkyl as end group, for example
RA0-(CHRB-CH2-0)n-CHRB-CH2- or
RA0-(CH2CH2CH2CH20)n-CH2CH2CH2CH20- where RA and RB are each preferably hydrogen, methyl or ethyl and n is preferably from 0 to 3, in particular 3-oxabutyl, 3-oxapentyl, 3,6-dioxaheptyl, 3,6-dioxaoctyl, 3,6,9-trioxadecyl, 3,6,9-trioxaundecyl, 3,6,9,12- tetraoxatridecyl and 3,6,9,12-tetraoxatetradecyl;
C2-C4-alkenyl such as vinyl and allyl; and
N,N-di-Ci-C6-alkylamino such as Ν,Ν-dimethylamino and N,N-diethylamino. Very particular preference is given to the radicals R1 to R9 each being, independently of one another, hydrogen; Ci-Cis-alkyl such as methyl, ethyl, 1 -butyl, 1 -pentyl, 1 -hexyl, 1 -heptyl,
1 - octyl; phenyl; 2-hydroxyethyl; 2-cyanoethyl; 2-(alkoxycarbonyl)ethyl such as
2- (methoxycarbonyl)ethyl, 2-(ethoxycarbonyl)ethyl or 2-(n-butoxycarbonyl)ethyl; N,N-(Ci-C4- dialkyl)amino such as Ν,Ν-dimethylamino or Ν,Ν-diethylamino; chlorine or a radical of oligoalkylene glycol, e.g. CH30-(CH2CH20)n-CH2CH2- or CH3CH20-(CH2CH20)n-CH2CH2- where n is from 0 to 3.
In the following described very particularly preferred [A+] cations (IVa) to (IVz) the substituent R has the following meaning:
R is a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under groups (I) to (VIII) above, for example substituted or unsub- stituted "alkyl", "arylalkyl", "alkenyl", "cycloalkyl", "cycloalkenyl", "polycyclyl", "aryl", "ar- yloxy", "arylthio", "heterocycloalkyl","heteroarayl", very preferably a straight chain or branched Ci to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl" residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
Very particularly preferred pyridinium ions (IVa) are those in which
- one of the radicals R1 to R5 is methyl, ethyl or chlorine and the remaining radicals R1 to R5 are each hydrogen;
- R3 is dimethylamino and the remaining radicals R1, R2, R4 and R5 are each hydrogen;
- all radicals R1 to R5 are hydrogen;
- R2 is carboxy or carboxamide and the remaining radicals R1, R2, R4 and R5 are each hydrogen; or
- R1 and R2 or R2 and R3 are 1 ,4-buta-1 ,3-dienylene and the remaining radicals R1, R3, R4 and R5 are each hydrogen;
and in particular those in which
- R1 to R5 are each hydrogen; or
- one of the radicals R1 to R5 is methyl or ethyl and the remaining radicals R1 to R5 are each hydrogen.
Particularly preferred pyridinium ions (IVa) are pyridinium, 2-methylpyridinium,
2-ethylpyridinium, 5-ethyl-2-methylpyridinium and 2-methyl-3-ethylpyridinium and also
1 -methylpyridinium, 1 -ethylpyridinium, 1 -(1 -butyl)pyridinium, 1 -(1 -hexyl)pyridinium, 1 -(1 - octyl)pyridinium, 1 -(1 -hexyl)pyridinium, 1 -(1 -octyl)pyridinium, 1 -(1 -dodecyl)pyridinium, 1 -(1 - tetradecyl)pyridinium, t-(1 -hexadecyl)pyridinium, 1 ,2-dimethylpyridinium, 1 -ethyl-2- methylpyridinium, 1 -(1 -butyl)-2-methylpyridinium, 1 -(1 -hexyl)-2-methylpyridinium, 1 -(1 -octyl)-2- methylpyridinium, 1-(1-dodecyl)-2-methylpyridinium, 1-(1-tetradecyl)-2-methylpyridinium, 1-(1- hexadecyl)-2-methylpyridinium, 1-methyl-2-ethylpyridinium, 1,2-diethylpyridinium, 1-(1-butyl)-2- ethylpyridinium, 1 -(1 -hexyl)-2-ethylpyridinium, 1 -(1 -octyl)-2-ethylpyridinium, 1 -(1 -dodecyl)-2- ethylpyridinium, 9-(1-tetradecyl)-2-ethylpyridinium, 1-(1-hexadecyl)-2-ethylpyridinium, 1,2- dimethyl-5-ethylpyridinium, 1,5-diethyl-2-methylpyridinium, 1-(1-butyl)-2-methyl-3-ethyl- pyridinium, 1-(1-hexyl)-2-methyl-3-ethylpyridinium and 1-(1-octyl)-2-methyl-3-ethylpyridinium, 1- (1-dodecyl)-2-methyl-3-ethylpyridinium, 1-(1-tetradecyl)-2-methyl-3-ethylpyridinium and 1-(1- hexadecyl)-2-methyl-3-ethylpyridinium.
Particularly preferred pyridazinium ions (IVb) are those in which
the radicals R1 to R4 are each hydrogen or
one of the radicals R1 to R4 is methyl or ethyl and the remaining radicals R1 to R4 are each hydrogen.
Particularly preferred pyrimidinium ions (IVc) are those in which
R1 is hydrogen, methyl or ethyl and R2 to R4 are each, independently of one another, hydrogen or methyl, or
R1 is hydrogen, methyl or ethyl and R2 and R4 are each methyl and R3 is hydrogen.
Particularly preferred pyrazinium ions (IVd) are those in which
R1 is hydrogen, methyl or ethyl and R2 to R4 are each, independently of one another, hydrogen or methyl, or
R1 is hydrogen, methyl or ethyl and R2 and R4 are each methyl and R3 is hydrogen, or
R1 to R4 are each methyl or
R1 to R4 are each hydrogen.
Particularly preferred imidazolium ions (IVe) are those in which
R1 is hydrogen, methyl, ethyl, 1 -propyl, 1 -butyl, 1-pentyl, 1 -hexyl, 1-octyl, dodecyl,
2-hydroxyethyl or 2-cyanoethyl and R2 to R4 are each, independently of one another, hydrogen, methyl or ethyl.
Particularly useful imidazolium ions (IVe) are 1 -methylimidazolium, 1-ethylimidazolium, 1-(1- propyl)imidazolium, 1-(1-allyl)imidazolium, 1-(1-butyl)imidazolium, 1-(1-octyl)imidazolium, 1-(1- dodecyl)imidazolium, 1-(1-tetradecyl)imidazolium, 1-(1-hexadecyl)imidazolium, 1,3- dimethylimidazolium, 1,3-diethylimidazolium, 1-ethyl-3-methylimidazolium, 1-(1-butyl)-3- methylimidazolium, 1 -(1 -butyl)-3-ethylimidazolium, 1 -(1 -hexyl)-3-methylimidazolium, 1 -(1 -hexyl)- 3-ethylimidazolium, 1 -(1 -hexyl)-3-butylimidazolium, 1 -(1 -octyl)-3-methylimidazolium, 1 -(1 -octyl)- 3-ethylimidazolium, 1-(1-octyl)-3-butylimidazolium, 1-(1-dodecyl)-3-methylimidazolium, 1-(1- dodecyl)-3-ethylimidazolium, 1-(1-dodecyl)-3-butylimidazolium, 1-(1-dodecyl)-3- octylimidazolium, 1-(1-tetradecyl)-3-methylimidazolium, 1-(1-tetradecyl)-3-ethylimidazolium, 1 -(1 -tetradecyl)-3-butylimidazolium, 1 -(1 -tetradecyl)-3-octylimidazolium, 1 -(1 -hexadecyl)-3- methylimidazolium, 1 -(1 -hexadecyl)-3-ethylimidazolium, 1 -(1 -hexadecyl)-3-butylimidazolium, 1 - (1 -hexadecyl)-3-octylimidazolium, 1 ,2-dimethylimidazolium, 1 ,2,3-trimethylimidazolium, 1 -ethyl-
2.3- dimethylimidazolium, 1 -(1 -butyl)-2,3-dimethylimidazolium, 1 -(1 -hexyl)-2,3- dimethylimidazolium, 1 -(1 -octyl)-2,3-dimethylimidazolium, 1 ,4-dimethylimidazolium, 1 ,3,4- trimethylimidazolium, 1 ,4-dimethyl-3-ethylimidazolium, 3-methylimidazolium, 3-ethylimidazolium, 3-n-propylimidazolium, 3-n-butylimidazolium, 1 ,4-dimethyl-3-octylimidazolium,
1 ,4,5-trimethylimidazolium, 1 ,3,4,5-tetramethylimidazolium, 1 ,4,5-trimethyl-3-ethylimidazolium, 1 ,4,5-trimethyl-3-butylimidazolium, 1 ,4,5-trimethyl-3-octylimidazolium, 1 -(prop-1 -en-3-yl)-3- methylimidazolium and 1 -(prop-1 -en-3-yl)-3-butylimidazolium. Especially suitable imidazolium ions (IVe) are 1 ,3-diethylimidazolium, 1 -ethyl-3-methylimidazolium, 1 -(n-butyl)-3- methylimidazolium.
Particularly preferred pyrazolium ions (IVf), (IVg) and (IVg') are those in which R1 is hydrogen, methyl or ethyl and R2 to R4 are each, independently of one another, hydrogen or methyl.
Particularly preferred pyrazolium ions (IVh) are those in which
R1 to R4 are each, independently of one another, hydrogen or methyl.
As particularly preferred pyrazolium ions, mention may be made of pyrazolium and
1 .4- dimethylpyrazolium.
1 -Pyrazolinium ions (IVi) used in the process of the invention are particularly preferably those in which
R1 to R6 are each, independently of one another, hydrogen or methyl.
Particularly preferred 2-pyrazolinium ions (IVj) and (IVj') are those in which
R1 is hydrogen, methyl, ethyl or phenyl and R2 to R6 are each, independently of one another, hydrogen or methyl.
Particularly preferred 3-pyrazolinium ions (IVk) and (IVk') are those in which
R1 and R2 are each, independently of one another, hydrogen, methyl, ethyl or phenyl and R3 to
R6 are each, independently of one another, hydrogen or methyl.
Particularly preferred imidazolinium ions (IV I) are those in which
R1 and R2 are each, independently of one another, hydrogen, methyl, ethyl, 1 -butyl or phenyl and R3 and R4 are each, independently of one another, hydrogen, methyl or ethyl and R5 and R6 are each, independently of one another, hydrogen or methyl.
Particularly preferred imidazolinium ions (IVm) and (IVm') are those in which
R1 and R2 are each, independently of one another, hydrogen, methyl or ethyl and R3 to R6 are each, independently of one another, hydrogen or methyl. Particularly preferred imidazolinium ions (IVn) and (IVn') are those in which
R1 to R3 are each, independently of one another, hydrogen, methyl or ethyl and R4 to R6 are each, independently of one another, hydrogen or methyl. Particularly preferred thiazolium ions (IVo) and (IVo') and oxazolium ions (IVp) are those in which
R1 is hydrogen, methyl, ethyl or phenyl and R2 and R3 are each, independently of one another, hydrogen or methyl. 1 ,2,4-Triazolium ions (IVq), (IVq') and (IVq") used in the process of the invention are particularly preferably those in which
R1 and R2 are each, independently of one another, hydrogen, methyl, ethyl or phenyl and R3 is hydrogen, methyl or phenyl. Particularly preferred 1 ,2,3-triazolium ions (IVr), (IVr') and (IVr") are those in which
R1 is hydrogen, methyl or ethyl, R2 and R3 are each, independently of one another, hydrogen or methyl or R2 and R3 are together 1 ,4-buta-1 ,3-dienylene.
Particularly preferred pyrrolidinium ions (IVs) are those in which
R1 is hydrogen, methyl, ethyl, butyl or phenyl and R2 to R9 are each, independently of one another, hydrogen or methyl.
Particularly preferred imidazolidinium ions (IVt) are those in which
R1 and R4 are each, independently of one another, hydrogen, methyl, ethyl or phenyl and R2, R3 and R5 to R8 are each, independently of one another, hydrogen or methyl.
Particularly preferred guanidinium ions (IVv) are those in which
R1 to R5 are methyl, ethyl or butyl. As very particularly preferred guanidinium ions (IVv), mention may be made of Ν,Ν,Ν',Ν' -tetrabutyl-N",N'-'dimethylguanidinium, N,N,N',N',N"-Pentabutyl-N"- methylguanidinium, N,N,N',N'-Tetrabutyl-N"-ethyl-N"-methylguanidinium.
Particularly preferred cholinium ions (IVw) are those in which
R1 and R2 are each, independently of one another, methyl, ethyl, 1 -butyl or 1 -octyl and R3 is hydrogen, methyl, ethyl, acetyl, -SO2OH or -PO(OH)2, or
R1 is methyl, ethyl, 1 -butyl or 1 -octyl, R2 is a -CH2-CH2-OR4 group and R3 and R4 are each, independently of one another, hydrogen, methyl, ethyl, acetyl, -SO2OH or -PO(OH)2, or
R1 is a -CH2-CH2-OR4 group, R2 is a -CH2-CH2-OR5 group and R3 to R5 are each, independently of one another, hydrogen, methyl, ethyl, acetyl, -SO2OH or -PO(OH)2. As cholinium ions (IVw), particular preference is given to those in which R3 is selected from among hydrogen, methyl, ethyl, acetyl, 5-methoxy-3-oxapentyl, 8-methoxy-3,6-dioxaoctyl, 1 1 - methoxy-3,6,9-trioxaundecyl, 7-methoxy-4-oxaheptyl, 1 1 -methoxy-4,8-dioxaundecyl, 15- methoxy-4,8,12-trioxapentadecyl, 9-methoxy-5-oxanonyl, 14-methoxy-5,10-oxatetradecyl, 5- ethoxy-3-oxapentyl, 8-ethoxy-3,6-dioxaoctyl, 1 1 -ethoxy-3,6,9-trioxaundecyl, 7-ethoxy-4- oxaheptyl, 1 1 -ethoxy-4,8-dioxaundecyl, 15-ethoxy-4,8,12-trioxapentadecyl, 9-ethoxy-5-oxanonyl or 14-ethoxy-5,10-oxatetradecyl.
The cations (IV.x.1 ) are particularly preferably selected from among cations of
1 ,5-diazabicyclo[4.3.0]non-5-ene (DBN) and 1 ,8-diazabicyclo[5.4.0]undec-7-ene (DBU).
Particularly preferred phosphonium ions (IVy) are those in which
R1 to R3 are each, independently of one another, Ci-Cis-alkyl, in particular methyl, butyl, isobu- tyl, 1 -hexyl or 1 -octyl, or phenyl which is unsubstituted or bears 1 , 2, 3, 4 or 5 substituents selected independently from among Ci-Cis-alkyl, carboxylate, sulfonate, COOH and SO3H.
Particularly preferred sulfonium ions (IVz) are those in which
R1 and R2 are each, independently of one another, Ci-Cis-alkyl, in particular butyl, isobutyl,
1 - hexyl or 1 -octyl.
Among the abovementioned heterocyclic cations, the imidazolium ions, imidazolinium ions, pyr- rolidinium ions, guanidinium ions and phosphonium ions are preferred.
Particular preference is given to the imidazolium ions.
Very preferably [A]+ cations are selected amongst the following groups (i) to (iv):
In the following described very preferred [A+] cations (i) to (iv) the substituent R has the following meaning:
R is a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under groups (I) to (VIII) above, for example substituted or unsubstituted "alkyl", "arylalkyl", "alkenyl", "cycloalkyl", "cycloalkenyl", "polycyclyl", "aryl", "ar- yloxy", "arylthio", "heterocycloalkyl","heteroarayl", very preferably a straight chain or branched Ci to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl" residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
(i) imidazolium ions (IVe) in which
R1 is hydrogen, methyl, ethyl, 1 -propyl, 1 -butyl, 1 -pentyl, 1 -hexyl, 1 -octyl, dodecyl,
2- hydroxyethyl or 2-cyanoethyl and R2 to R4 are each, independently of one another, hydrogen, methyl or ethyl.
Particularly useful imidazolium ions (IVe) are 1 -methylimidazolium, 1 -ethylimidazolium, 1 -(1 - propyl)imidazolium, 1 -(1 -allyl)imidazolium, 1 -(1 -butyl)imidazolium, 1 -(1 -octyl)imidazolium, 1 -(1 - dodecyl)imidazolium, 1 -(1 -tetradecyl)imidazolium, 1 -(1 -hexadecyl)imidazolium, 1 ,3- dimethylimidazolium, 1 ,3-diethylimidazolium, 1 -ethyl-3-methylimidazolium, 1 -(1 -butyl)-3- methylimidazolium, 1 -(1 -butyl)-3-ethylimidazolium, 1 -(1 -hexyl)-3-methylimidazolium, 1 -(1 -hexyl)- 3-ethylimidazolium, 1 -(1 -hexyl)-3-butylimidazolium, 1 -(1 -octyl)-3-methylimidazolium, 1 -(1 -octyl)- 3-ethylimidazolium, 1 -(1 -octyl)-3-butylimidazolium, 1 -(1 -dodecyl)-3-methylimidazolium, 1 -(1 - dodecyl)-3-ethylimidazolium, 1 -(1 -dodecyl)-3-butylimidazolium, 1 -(1 -dodecyl)-3- octylimidazolium, 1 -(1 -tetradecyl)-3-methylimidazolium, 1 -(1 -tetradecyl)-3-ethylimidazolium, 1 -(1 -tetradecyl)-3-butylimidazolium, 1 -(1 -tetradecyl)-3-octylimidazolium, 1 -(1 -hexadecyl)-3- methylimidazolium, 1 -(1 -hexadecyl)-3-ethylimidazolium, 1 -(1 -hexadecyl)-3-butylimidazolium, 1 - (1 -hexadecyl)-3-octylimidazolium, 1 ,2-dimethylimidazolium, 1 ,2,3-trimethylimidazolium, 1 -ethyl- 2,3-dimethylimidazolium, 1 -(1 -butyl)-2,3-dimethylimidazolium, 1 -(1 -hexyl)-2,3- dimethylimidazolium, 1 -(1 -octyl)-2,3-dimethylimidazolium, 1 ,4-dimethylimidazolium, 1 ,3,4- trimethylimidazolium, 1 ,4-dimethyl-3-ethylimidazolium, 3-methylimidazolium, 3-ethylimidazolium, 3-n-propylimidazolium, 3-n-butylimidazolium, 1 ,4-dimethyl-3-octylimidazolium,
1 ,4,5-trimethylimidazolium, 1 ,3,4,5-tetramethylimidazolium, 1 ,4,5-trimethyl-3-ethylimidazolium, 1 ,4,5-trimethyl-3-butylimidazolium, 1 ,4,5-trimethyl-3-octylimidazolium, 1 -(prop-1 -en-3-yl)-3- methylimidazolium and 1 -(prop-1 -en-3-yl)-3-butylimidazolium. Especially suitable imidazolium ions (IVe) are 1 ,3-diethylimidazolium, 1 -ethyl-3-methylimidazolium, 1 -(n-butyl)-3- methylimidazolium.
(ii) pyrrolidinium ions (IVs) in which
R1 is hydrogen, methyl, ethyl, butyl or phenyl and R2 to R9 are each, independently of one another, hydrogen or methyl.
(iii) guanidinium ions (IVv) in which
R1 to R5 are methyl, ethyl or butyl. As very particularly preferred guanidinium ions (IVv), men- tion may be made of Ν,Ν,Ν',Ν' -tetrabutyl-N",N'-'dimethylguanidinium, Ν,Ν,Ν',Ν',Ν''-Pentabutyl- N"-methylguanidinium, N,N,N',N'-Tetrabutyl-N"-ethyl-N"-methylguanidinium
(iv) phosphonium ions (IVy) in which
R1 to R3 are each, independently of one another, Ci-Cis-alkyl, in particular methyl, butyl, isobu- tyl, 1 -hexyl or 1 -octyl, or phenyl which is unsubstituted or bears 1 , 2, 3, 4 or 5 substituents selected independently from among Ci-Cis-alkyl, carboxylate, sulfonate, COOH and SO3H.
X is in general formula (I) a Ci to C30 organic residue as defined above, which can be preferably selected from residues defined herein under (I) to (X) above, for example substituted or unsubstituted "alkyl", "alkyl", "arylalkyl", "alkenyl", "cycloalkyl", "cycloalkenyl", "polycyclyl", "aryl", "ar- yloxy", "arylthio", "heterocycloalkyl","heteroarayl", all as defined herein, most preferably a straight chain or branched Ci to C30 alkyl; examples of the alkyl are given herein under the definition of "alkyl" in (I). Examples for suitable monosubstituted oxalic acid derivatives of the general formula (I) are those wherein A is selected from the group consisting of the above defined compounds IV. a to IV.z and X is selected from the group consisting of straight chain or branched C1-C30 alkyl. Examples for very suitable monosubstituted oxalic acid derivatives of the general formula (I) are those wherein A is selcted from the group consisting of the above defined compounds IV.e (im- idazolium), IVs (pyrrolidinium), IVv (guanidinium) , IVy (phosphonium) and X is selected from the group consisting of unsubstituted straight chain or branched Ci to C30 alkyl residues, preferably as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
Examples for preferred monosubstituted oxalic acid derivatives of the general formula (I) are those, wherein A is selected from the group consisting of the above described compounds IV.e (imidazolium) and X is selected from the group consisting of of unsubstituted straight chain or branched Ci to C30 alkyl residues, preferably as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl.
Monosubstituted oxalic acid derivatives of the general formula (I) are preferably in the state of an ionic liquid.
For the purpose of the resent patent application ionic liquids are organic salts which are liquid at temperatures below 180 °C, preferably below 130 °C, very preferably below 75 °C, most preferably below 25 °C.
In general the melting points of the oxalic acid derivatives of the general formula (I) are in a range of from - 50 °C to 180 °C, more preferably in the range of from - 20 °C to 130 °C.
The oxalic acid derivatives of the general formula (I) are prepared by the reaction of an oxalic acid compound of the general formula (II)
R10-C(0)-C(0)-0-X (I I) with the organic moiety A as defined above (including all modes), however wherein the heteroa- tom in the precursor is not yet formally positively charged.
R1 has the meaning of R as defined above, including all modes. R1 and X can be the same or different. Preferably at least one of R1 and X is a straight chain or branched Ci to C30 alkyl and most preferably unsubstituted straight chain or branched Ci to C30 "alkyl" residues as defined in group (I) above, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecylvery preferably at least one of R1 and X is methyl, ethyl, propyl, butyl, dodecyl most preferably at least one of R1 and X is methyl, ethyl, propyl, in particular R1 and X are me- thyl. Examples for oxalic acid derivatives of the general formula (II) are described in the section„Ex- amples" of this application.
The monosubstituted oxalic acid derivatives of the general formula (I) (without disclaimer), pref- erably those which are in the state of an ionic liquid, can be used to at least partially dissolve inorganic or organic material, for example metal compounds such as compounds of rare earth elements or actinide elements.
The monosubstituted oxalic acid derivatives of the general formula (I) (without disclaimer), pref- erably those which are in the state of an ionic liquid, can be used in a separation process for metals, in a separation process for rare earth elements and actinide elements, for example in liquid-liquid extraction processes for the separation of metals for example the separation of rare earth elements from each other. EXAMPLES
A) Synthesis of ionic monosubstituted oxalic acid derivatives
Example 1
N,N,N',N',N"-Pentabutyl-N"-methylguanidinium-methyloxalate
Figure imgf000029_0001
17.12 g (50.6 mmol) of Ν,Ν,Ν',Ν',Ν''-pentabutylguanidine and 8.75 g (74.2 mmol) dimethyloxa- late were stirred for 12 hours at 130 °C. The mixture was washed with hexanes and dried in vacuo. 20.9 g (45.6 mmol, 90%) of a brown oily liquid were obtained.
H-NMR (CDsCN, 300 MHz): δ = 3.24 (s, 3H, HC8), 3.23 - 2.90 (m, 10H, HC3), 2.86 (s, 3H, HC2), 1 .77 - 1 .13 (m, 20H, HC4,5), 0.87 (t, 15H, 3JHH = 7.2 Hz, HC6) ppm.
3C-NMR (CDsCN, 75 MHz): δ =164.9 (C1 ,7'), 157.4 (C7), 53.5 (C8), 51.7, 50.5, 50.1 , 50.1 , 49.7 (C3), 38.7 (C2), 30.4, 30.3, 30.2, 30.1 , 30.0 (C4), 20.7 (C5), 14.0 (C6) ppm.
IR: v = 2956 (m), 2931 (m), 2871 (m), 1677 (s), 1535 (s), 1457 (m), 1433 (m), 1378 (w), 1314 (w), 1270 (s), 1 174 (w), 1 1 10 (w), 1066 (s), 940 (w), 891 (w), 843 (m), 739 (w) crrr1.
Elemental analyses: C25H51 N3C (457.69 9/m0i) calculated: C 65.60% H 1 1.23% N 9.18%
found: C 64.61 % H 1 1.83% N 10.39%
Example 2
N,N,N',N'-Tetrabutyl-N"-ethyl-N"-methylguanidinium-methyloxalate
Figure imgf000030_0001
0.40 g (1.27 mmol) N,N,N',N'-tetrabutyl-N"-ethylguanidine and 0.25 g (2.13 mmol) dime- thyloxalate in 0.5 ml acetonitrile were stirred for three days at 80 °C. The mixture was dried in vacuo, dissolved in a mixture of acetonitrile and diethylether (1 :1 ), washed three times with hexanes and dried in vacuo. 0.54 g (1.26 mmol, 99%) of a yellow oily liquid were obtained. H-NMR (CDsCN, 300 MHz): δ = 3.53 (s, 3H, HC8), 3.32 - 2.90 (m, 10H, HC3,3<) , 2.85 (s, 3H, HC2), 1 .75 - 1 .20 (m, 16H, HC4,5), 1.16 (t, 3H, 3JHH = 7.2 Hz, HC4 <), 0.88 (2xt, 12H, 3JHH = 7.3 Hz, Hce) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 169.3 (C7'), 164.7 (C1 ), 164.0 (C7), 50.5 (C8), 50.4, 50.2, 50.0, 49.7 (C3'), 48.4 (C8), 37.9 (C2), 30.4, 30.2, 30.1 , 30.0 (C4), 20.66, 20.58, 20.6 (C5), 14.0 (C4'), 13.0 (C6) ppm. IR: v = 2956 (m), 2932 (m), 2871 (m), 1716 (m), 1636 (s), 1537 (s), 1457 (m), 1363 (m),
1323 (w), 1 186 (m), 1 158 (s), 1 1 12 (w), 1094 (w), 1058 (w), 991 (w), 943 (w), 894 (w), 853 (w), 805 (w), 752 (m) cm"1.
Elemental analyses: C23H47N304 (429.64 9/m0i)
calculated: C 64.30% H 1 1.03% N 9.78%
found: C 63.17% H 10.94% N 10.1 1 %
Example 3 N,
Figure imgf000030_0002
0.43 g (1.46 mmol) N,N,N',N'-tetrabutyl-N"-methylguanidine and 0.38 g (3.23 mmol) dime- thyloxalate were stirred for three days at 100 °C. The mixture was washed with hexanes and dried in vacuo. 0.52 g (1 .26 mmol, 86%) of a brown oil were obtained. H-NMR (CDsCN, 300 MHz): δ = 3.55 (s, 3H, HC8), 3.28 - 2.95 (m, 8H, HC3), 2.86 (s, 6H, HC2), 1 .75 - 1 .19 (m, 16H, HC4,s), 0.90 (t, 12H, 3JHH = 7.2 Hz, HC6) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 169.1 (C7'), 164.5 (C1 ), 164.0 (C7), 54.1 (C8), 50.5, 49.7 (C3), 40.8 (C2), 30.4, 30.1 (C4), 20.7, 20.6 (C5), 13.9 (C6) ppm.
IR: v = 2956 (m), 2932 (m), 2871 (m), 1770 (w), 1715 (m), 1635 (s), 1578 (m), 1537 (s), 1458 (m), 1418 (m), 1364 (m), 1317 (w), 1249 (w), 1216 (m), 1 185 (w), 1 157 (s), 1 1 12 (w), 1062 (w), 991 (w), 940 (w), 891 (w), 852 (w), 800 (w), 752 (m) cm"1.
Elemental analyses: C22H45N3O4 (415.61 9/m0i)
calculated: C 63.58% H 10.91 % N 10.1 1 %
found: C 61.16% H 1 1.26% N 9.57%
Example 4
Figure imgf000031_0001
1 .96 g (23.91 mmol) N-methylimidazole and 3.03 g (25.62 mmol) dimethyloxalate in 0.5 mL ace- tonitrile were stirred for three days at 90 °C. The mixture was washed with hexanes and dried in vacuo. 4.68 g (23.43 mmol, 98%) of a yellow liquid were obtained. H-NMR (CDsCN, 300 MHz): δ = 9.62 (s, 1 H, HCi), 7.61 (d, 2H, 4JHH = 1.6 Hz, HC2,2<), 3.83 (s, 3H, Hcs), 3.83 (s, 3H, HC3 <), 3.53 (s, 3H, HC4) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 169.6 (C4'), 164.9 (C4), 140.0 (C1 ), 125.2 (C2,2'), 51.8 (C5), 37.1 (C3,3') ppm.
IR: v = 3076 (w), 2952 (w), 2858 (w), 1713 (m), 1627 (s), 1573 (m), 1455 (w), 1371 (m), 1 196 (m), 1 170 (s), 1089 (w), 977 (w), 858 (w), 755 (m), 715 (w), 625 (w) cm"1. Elemental analyses: C8H12N2O4 (200.19 9/m0i)
calculated: C 48.00% H 6.04% N 13.99%
found: C 47.21 % H 6.48% N 14.06% Example 5
N-Butyl-N'-methylimidazolium-methyloxalate
Figure imgf000032_0001
1 .28 g (10.31 mmol) N-butylimidazole and 3.69 g (30.92 mmol) dimethyloxalate were stirred for four days at 90 °C. The mixture was washed with hexanes and dried in vacuo. 2.40 g
(9.93 mmol, 96%) of a yellow oil were obtained. H-NMR (CDsCN, 300 MHz): δ = 9.78 (s, 1 H, HCi), 7.65 (2xt, 2H, 4JHH = 1.5 Hz, HC2,2<), 4.17 (t, 2H, 3JHH = 7.2 Hz, He*), 3.85 (s, 3H, HC3), 3.54 (s, 3H, Hce), 1.80 - 1 .67 (m, 2H, HC5), 1.28 - 1.13 (m, 2H, Hce), 0.89 (t, 3H, 3JHH = 7.4 Hz, HC7) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 168.8 (C9'), 164.2 (C9), 138.8 (C1 ), 124.6 (C2), 123.3 (C2'), 51.0 (C8), 49.8 (C3), 36.4 (C4), 32.7 (C5), 19.9 (C6), 13.8 (C7) ppm.
IR: v = 2958 (w), 2873 (w), 1715 (m), 1628 (s), 1568 (m), 1461 (w), 1370 (m), 1 195 (m), 1 168 (s), 980 (w), 858 (w), 755 (m), 654 (w), 625 (w), 409 (w) cm"1.
Elemental analyses: CiiHi8N204 (242.27 9/m0i)
calculated: C 54.53% H 7.49% N 1 1.56%
found: C 54.50% H 8.08% N 12.95%
Example 6 N-
Figure imgf000032_0002
1 .65 g (6.96 mmol) N-Dodecylimidazole and 2.50 g (21 .14 mmol) dimethyloxalate in 5 mL ace- tonitrile were stirred for two days at 90 °C. The mixture was washed with hexanes and dried in vacuo. 2.30 g (6.46 mmol, 93%) of a colorless solid were obtained. H-NMR (CDsCN, 300 MHz): δ = 9.55 (s, 1 H, HCi), 7.47 (2xt, 2H, 4JHH = 1.8 Hz, HC2,2<), 4.16 (t, 2H, 3JHH = 7.3 Hz, HC4), 3.87 (s, 3H, HC3), 3.59 (s, 3H, HC8), 1.87 - 1 .74 (m, 2H, HC5), 1.34 - 1.22 (m, 18H, Hce), 0.86 (t, 3H, 3JHH = 6.7 Hz, HC7) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 168.7 (C9'), 164.1 (C9), 138.5 (C1 ), 124.4 (C2), 123.1 (C2'), 50.9 (C8), 50.2 (C4), 36.6 (C3), 32.6 (C5), 30.7, 30.3, 30.2, 30.1 , 30.0, 29.6, 26.7, 23.3 (C6), 14.3 (C7) ppm. IR: v = 3059 (w), 2916 (m), 2850 (w), 171 1 (m), 1630 (s), 1567 (w), 1467 (w), 1470 (w),
1401 (m), 1 194 (m), 1 165 (s), 1088 (w), 1018 (w), 990 (w), 876 (w), 856 (w), 814 (w), 753 (m), 657 (w), 628 (w) cm"1.
Elemental analyses: C19H34N2O4 (355.49 9/m0i)
calculated: C 64.38% H 9.67% N 7.90%
found: C 64.15% 1-1 9.91 % N 7.84%
Example 7 N,N-Dimethylamino-N'-methylpyridinium-methyloxalate
Figure imgf000033_0001
1 .01 g (8.20 mmol) Ν,Ν-Dimethylaminopyridine and 1.26 g (10.7 mmol) dimethyloxalate in 1 mL acetonitrile were stirred for one day at 90 °C. The mixture was added dropwise to hexanes and diethylether was added until a oily phase formed. The oil was was separated, washed with hexanes and evaporated in vacuo. 1.84 g (7.67 mmol, 94%) of a yellow brownish solid were obtained. The melting point is below 100 °C.
1 H-NMR (CD3CN, 300 MHz): δ = 8.20 (d, 2H, 3JHH = 7.8 Hz, HC4.4"), 6.88 (d, 2H, 3JHH = 7.8 Hz, HC3.3'), 3.90 (s, 3H, HC5), 3.55 (s, 3H, HC6), 3.12 (s, 6H, HC1.1 ') ppm.
13C-NMR (CD3CN, 75 MHz): δ = 168.7 (C7"), 164.1 (C7), 157.0 (C2), 144.0 (C4,4'), 108.4 (C3,3'), 50.9 (C6), 44.9 (C5), 40.4 (C1 ,1 ') ppm.
IR: v = 2998 (w), 2880 (w), 1710 (m), 1623 (s), 1563 (s), 1540 (m), 1507 (w), 1440 (w), 1386 (m), 1369 (m), 1241 (w), 1 190 (s), 1 164 (s), 1063 (w), 1028 (w), 965 (m), 943 (m), 860 (m), 840 (m), 805 (w), 751 (s), 639 (w), 614 (w), 506 (m) cm-1 . Example 8
Figure imgf000034_0001
3.88 g (30.5 mmol) N-Butylpyrrolidine and 5.40 g (45.7 mmol) dimethyloxalate in 5 mL acetoni- trile were stirred for one day at 90 °C. The mixture was washed with hexanes/diethyhether (10:1 ) and dried in vacuo. 7.14 g (29.12 mmol, 95%) of a golden colored oil were obtained. H-NMR (CDsCN, 300 MHz): δ = 3.56 (s, 3H, Hce), 3.55 - 3.42 (m, 4H, HC2,z), 3.37 - 3.29 (m, 2H, Hc4), 3.00 (s, 3H, HC3), 2.17 - 2.05 (m, 4H, HCi,cr), 1.75 - 1 .61 (m, 2H, HC5), 1.39 - 1 .24 (m, 2H, Hce), 0.91 (t, 3H, 3JHH = 7.3 Hz, HC7) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 168.8 (C9'), 164.1 (C9), 64.8 (C2,2'), 64.5 (C4), 50.8 (C8), 48.7 (C3), 26.2 (C5), 22.2 (C1 ,1 '), 20.4 (C6), 13.8 (C7) ppm.
IR: v = 2960 (m), 2876 (w), 1712 (s), 1629 (s), 1464 (m), 1369 (m), 1 192 (s), 1 165 (s), 1063 (w), 980 (m), 930 (m), 857 (w), 806 (w), 754 (s) cm"1.
Example 9
Tributylmethylphosphonium-methyloxalate
Figure imgf000034_0002
0.92 g (4.53 mmol) tributylphosphine and 0.71 g (6.05 mmol) dimethyloxalate in 2.5 mL acetoni- trile were stirred for two days at 90 °C. The mixture was washed with hexanes and dried in vacuo. 1 .42 g (4.43 mmol, 98%) of a colorless oil were obtained. H-NMR (CDsCN, 300 MHz): δ = 3.55 (s, 3H, HC6), 2.27 - 2.1 1 (m, 6H, HC2), 1.79 (d, 3H, 2JPH = 13.9 Hz, Hci), 1.60 - 1 .29 (m, 12H, HC3,4), 0.89 (t, 9H, 3JHH = 7.1 Hz, HC5) ppm. 3C-NMR (CDsCN, 75 MHz): δ = 169.2 (C7'), 164.0 (C7), 50.6 (C6), 24.5 (d, 3JCp = 15.9 Hz, C4), 23.9 (d, 2Jcp = 4.5 Hz, C3), 20.3 (d, 1JCp = 49.5 Hz, C2), 13.7 (C5), 4.1 (d, 1JCp = 52.3 Hz, C1 ) ppm. 3 P-NMR (CDsCN, 122 MHz): δ = 31.59 (s) ppm.
IR: v = 2958 (m), 2932 (m), 2872 (w), 1716 (m), 1630 (s), 1463 (w), 1367 (m), 1310 (w), 1 189 (m), 1 162 (s), 1098 (w), 987 (w), 941 (m), 856 (w), 817 (w), 753 (m), 722 (w) cm"1.
Elemental analyses: C16H33O4P (320.40 9/m0i)
calculated: C 59.98% H 10.38%
found: C 59.99% H 1 1.60% Example 9a
Tributylmethylphosphonium-2-ethyl-hexyloxalat
Figure imgf000035_0001
1 .31 g (6.06 mmol, 1 ,00 eq) 2-Ethyl-hexylmethyloxalat and 2.05 g (10.13 mmol, 1.67 eq) Tribu- tylphosphin were heated for 65 h to 1 10 °C. The brownish reaction mixture was dried at low pressure(3 · 10"5 mbar, 90 °C, 1.5 h). Yield: 1 .97 g (4.72 mmol, 78%) of a brown oily product. H-NMR (300 MHz, MeCN-d3): δ / ppm = 3.93 - 3.85 (m, 2H, COOCH2CH(CH2CH3)(CH2)3CH3), 2.27 - 2.1 1 (m, 6H, H3CP(CH2(CH2)2CH3)3), 1 .80 (d, 3H, 2JPH = 13.9 Hz, H3CP(CH2(CH2)2CH3)3), 1 .63 - 1.21 (m, 21 H,
Figure imgf000035_0002
H3CP(CH2(CH2)2CH3)3), 0.97 - 0.82 (m, 15H, COOCH2CH(CH2CH3)(CH2)3CH3,
Figure imgf000035_0003
3C-NMR (75 MHz, MeCN-d3): δ / ppm = 169.0 (COO ), 164.4
(COOCH2CH(CH2CH3)(CH2)3CH3),
65.7 (COOCH2CH(CH2CH3)(CH2)3CH3), 39.7 (COOCH2CH(CH2CH3)(CH2)3CH3),
31.0 (COOCH2CH(CH2CH3)(CH2)3CH3), 29.6 (COOCH2CH(CH2CH3)CH2(CH2)2CH3), 24.5 (d,
3JPC = 16.0 Hz, H3CP((CH2)2CH2CH3)3), 24.4 (COOCH2CH(CH2CH3)CH2CH2CH2CH3), 23.9 (d,
2Jpc = 4.5 Hz, H3CP(CH2CH2CH2CH3)3), 23.7 (COOCH2CH(CH2CH3)(CH2)2CH2CH3), 20.2 (d, pc = 49.4 Hz, H3CP(CH2(CH2)2CH3)3) , 14.4 (COOCH2CH(CH2CH3)(CH2)3CH3), 13.7
(H3CP(CH2(CH2)2CH3)3),
1 1.3 (COOCH2CH(CH2CH3)(CH2)3CH3), 4.1 (d, 1 JPC = 52.2 Hz, H3CP(CH2(CH2)2CH3)3).
3 P-NMR (122 MHz, MeCN-d3): δ / ppm = 33.86 (s).
ESI-MS (MeOH): pos.: m/z (%) = 217.3 (100) [Ci3H3oP]+.
neg.: m/z (%) = 201.2 (100) [C10H17O4]-.
HR-MS (MeOH): pos.: m/z = gef. 217.2080, ber. 217.2082 [Ci3H30P]+.
neg.: m/z = gef.201.1 132, ber. 201 .1 134 [C10H17O4]-. Example 10
N-Butyl-N-meth lpyrrolidinium-dodecyloxala
Figure imgf000036_0001
N-Butylpyrrolidine (0.34 g, 2.66 mmol) and dodecylmethyloxalat (0.62 g, 2.42 mmol) in 3 mL of acetonitrile were stirred for six days at 86 °C, washed with hexanes and dried in vacuo. 0.69 g (74 %) of a yellow solid were obtained. The melting point is below 100 °C. H-NMR (300 MHz, MeCN-d3): δ / ppm = 0.85 (t, 3H, 3JHH = 6.7 Hz, (CH2)nCH3), 0.92 (t, 3H, 3JHH = 7.3 Hz, N(CH2)3CH3), 1.16 - 1.39 (m, 20H, N(CH2)2CH2CH3, 0(CH2)2(CH2)9CH3),
1 .51 - 1 .63 (m, 2H, OCH2CH2), 1 .63 - 1.76 (m, 2H, NCH2CH2CH2CH3), 2.05 - 2.18 (m, 4H, NCH2(CH2)2CH2N), 3.01 (s, 3H, NCH3), 3.30 - 3,42 (m, 2H, NCH2(CH2)2CH3), 3.46 - 3.58 (m, 4H, NCH2(CH2)2CH2N), 3.96 (t, 2H, 3JHH = 6.8 Hz, OCH2). 3C-NMR (75 MHz, MeCN-d3): δ / ppm = 13.9 (N(CH2)3CH3), 14.5 (0(CH2)nCH3),
20.5 (N(CH2)2CH2CH3), 22.3 (NCH2(CH2)2CH2N), 23.4 (OCH2(CH2)i0CH3),
26.3 (NCH2CH2CH2CH3), 26.8, 29.6, 30.1 , 30.3, 30.4, 30.4, 32.7 (OCH2(CH2)i0CH3),
48.8 (NCH3), 64.0 (OCH2(CH2)ioCH3), 64.5 (NCH2(CH2)2CH3), 64.9 (NCH2(CH2)2CH2N), 164.5 (COO(CH2)iiCH3), 168.6 (COO-).
IR: v / cm-1 = 2957 (w), 2920 (m), 2852 (m), 1714 (m), 1625 (s), 1468 (w), 1400 (w), 1371 (w), 1307 (w), 1 170 (s), 1061 (w), 1002 (w), 963 (w), 934 (w), 756 (m), 720 (w), 456 (w). Elemental analyses: C23H45N04 (399.61 g/mol)
calculated: C 69.13 % H 1 1.35 % N 3.51 %
found: C 68.88 % H 1 1.75 % N 3.55 %
Example 1 1
N-Dodecyl-N'-methylimidazolium-dodecyloxalate
Figure imgf000036_0002
N-Dodecylpyrrolidine (0.35 g, 1.47 mmol) and dodecylmethyloxalat (0.37 g, 1 .35 mmol) were stirred in 2 mL acetonitril at 90 °C for four days, washed with hexanes and dried in vacuo.
0.50 g (72 %) of a colorless solid were obtained. The melting point is below 100 °C.
1H-NMR (300 MHz, MeCN-d3): δ / ppm = 0.88 (t, 6H, 3JHH = 6.6 Hz, (CH2)nCH3), 1 .22 - 1.37 (m, 36H, (CH2)2(CH2)9CH3), 1.55 - 1 .66 (m, 2H, OCH2CH2), 1 .75 - 1.86 (m, 2H,NCH2CH2), 3.84 (s, 3H, NCHs), 3.99 (t, 2H, 3JHH = 6.8 Hz, OCH2), 4.13 (t, 2H, 3JHH = 7.3 Hz, NCH2), 7.35 - 7.41 (m, 2H, NCHCHN), 8.95 (s, 1 H, NCHN). 3C-NMR (75 MHz, MeCN-d3): δ / ppm = 14.4 ((CH2)nCH3), 23.4, 26.7, 26.8, 29.6, 29.7, 30.1 , 30.1 , 30.3, 30.3, 30.4, 30.4, 30.7, 32.7 (CH2(CH2)ioCH3), 36.7 (NCH2(CH2)ioCH3, 50.4 (NCH3), 64.0 (OCH2(CH2)ioCH3), 123.2 (CH3NCH2CH2), 124.5 (CH3NCH2CH2), 138.1 (NCHN), 164.7 (COO(CH2)iiCH3), 168.9 (COO").
IR: v / crrv1 = 3064 (w), 2954 (w), 2918 (s), 2849 (m), 1771 (w), 1746 (w), 1705 (m), 1626 (s), 1559 (w), 1506 (w), 1465 (w), 1396 (w), 1373 (w), 1315 (w), 1285 (w), 1228 (w), 1 179 (s), 1 165 (s), 1 108 (w), 1076 (w), 1015 (w), 986 (w), 961 (w), 905 (w), 878 (w), 815 (w), 794 (w), 767 (w), 749 (w), 723 (w), 661 (w), 631 (w), 530 (w), 471 (w).
Elemental analyses: C3oH56N204 (508.78 g/mol)
calculated: C 70.82 % H 1 1.09 % N 5.51 %
found: C 68.15 % H 10.85 % N 5.60 %
Example 12 N,N'-Dimethylimidazolium-tert-butyloxalat
Figure imgf000037_0001
Tert-butylmethyloxalat (0.42 g, 2.63 mmol) and N-methylimidazole (2.07 g, 25.21 mmol) were stirred in 2 mL Acetonitril for three days at 90 °C, washed with hexanes and dried in vacuo. 0.59 g (92 %) of a brown oil were obtained. H-NMR (300 MHz, MeCN-d3): δ / ppm = 1 .42 (s, 9H, C(CH3)), 3.86 (s, 6H,NCH3), 7.43 (s, 2H, N(CH)2N), 9.49 (s, 1 H, NCHN).
3C-NMR (75 MHz, MeCN-d3): δ / ppm = 28.4 (C(CH3)3), 36.6 (NCH3), 80.2 (C(CH3)3), 124.4 (N(CH)2N), 139.2 (NCHN), 165.4 (COOC(CH3)3), 168.2 (COO").
IR: v / cm-1 = 2977 (w), 1708 (m), 1618 (s), 1573 (m), 1458 (w), 1391 (w), 1364 (m), 1219 (m), 1 145 (s), 895 (w), 861 (w), 775 (s), 715 (w), 623 (m), 475 (w), 420 (w). Elemental analyses: CnHi8N204 (242.27 g/mol)
calculated: C 54.53 % H 7.49 % N 1 1.56 %
found: C 52.88 % H 7.43 % N 1 1.71 %
B) Dissolution of rare earth chloride hydrates Example 13
Dissolution of NdCI3-6H20 in N,N'-dimethylimidazolium-methyloxalate
0.15 g (0.40 mmol) of NdCI3-6H20 were completely dissolved in 1.39 g (6.96 mmol) of Ν,Ν'- dimethylimidazolium-methyloxalate ("IL") by stirring the mixture for 7 days at room temperature (about 20 °C).
The molar ratio of IL : NdCI3 »6H20 = 17 : 1
Example 13a
Dissolution of NdCI3 »6H20 in N,N'-dimethylimidazolium-methyloxalate
4.15 g (1 1 .6 mmol) of NdCI3 »6H20 were stirred in 20.34 g (0.10 mol) of Ν,Ν'- dimethylimidazolium-methyloxalate ("IL") for three days at room temperature (about 20 °C). Af- ter this time, the liquid phase was isolated by centrifugation at 4000 rpm and analyzed by ICP- MS. The Nd content in the IL phase was 0.43g/100 g. This is equivalent to 5% of neodymium dissolved in the IL phase.
The molar ratio of IL : NdCI3 »6H20 = 8,6 : 1
Example 14
Dissolution of SmCI3-6H20 in N,N'-dimethylimidazolium-methyloxalate
0.24 g (0.67 mmol) of SmCI3-6H20 were completely dissolved in 1.68 g (8.39 mmol) of Ν,Ν'- dimethylimidazolium-methyloxalate ("IL") by stirring the mixture for 5 days at room temperature (about 20 °C).
The molar ratio of IL : SmCI3 »6H20 = 12,5 : 1 Example 14a
Dissolution of SmCI3 »6H20 in N,N'-dimethylimidazolium-methyloxalate
4.32 g (12.0 mmol) of SmCI3 »6H20 were stirred in 20.23 g (0.10 mol) of Ν,Ν'- dimethylimidazolium-methyloxalate ("IL") for three days at room temperature (about 20 °C). After this time, the liquid phase was isolated by centrifugation at 4000 rpm and analyzed by ICP- MS. The Sm content in the IL phase was 6.5 g/100 g. This is equivalent to 72% of samarium dissolved in the IL phase.
The molar ratio of IL : SmCI3 »6H20 = 8,33 : 1
Example 15
Dissolution of LaCI3 »7H20 in N,N'-dimethylimidazolium-methyloxalate 4.06 g (10.9 mmol) of LaCI3*7H20 were stirred in 20.10 g (0.10 mol) of Ν,Ν'- dimethylimidazolium-methyloxalate ("IL") for three days at room temperature (about 20 °C). After this time, the liquid phase was isolated by centrifugation at 4000 rpm and analyzed by ICP- MS. The La content in the IL phase was 0.35 g/100 g. This is equivalent to 4% of lanthanum dissolved in the IL phase.
The molar ration of IL : LaCI3*7H20 = 9,2 : 1
The above experiments indicate that the IL can discriminate rare earth chlorides at least exem- plified here by the different solubility of samariumtrichloride versus the trichlorides of lanthanum or neodymium.
Example 16
Recovery of Sm salt from IL solution
0.126 g (0.35 mmol) of SmCI3*6H20 were stirred in 10.13 g (50.6 mmol) of Ν,Ν'- dimethylimidazolium-methyloxalate ("IL") for 5 hours at room temperature (about 20 °C). Solid material was removed by centrifugation at 4000 rpm. The Sm content of the solution was 0.43 g/100g, as confirmed by ICP-MS analysis. This is equivalent to 83.8% of Sm dissolved in the IL phase. 4 mL of 1 M hydrochloric acid was added to the mixture, and a colorless solid precipitated. The supernatant was isolated by centrifugation. The Sm content of the solution was <0.01 g/100g.
Example 17
Size selective two phase liquid extraktion of a mixture of six rare earth metal chlorides by Tribu- tyl-methylphosphonium-2-ethyl-hexyloxalat
2.070 g of an aqueous solution containing Lanthanum-, Cer-, Neodym-, Samarium-, Europium- und Ytterbiumtrichloride (in total 0.101 mmol, the quantitative composition is shown in the lower part of the following table) were stirred together with 3.612 g of an solution of 1 .974 g
(4.716 mmol) Tributyl-methylphosphonium-2-ethyl-hexyloxalat in 9.433 g dichlormethane for a duration of 20 minutes at room temperature. The phases were separated after a waiting time of 5 minutes. The aqueous phase was analyzed by the method ICP-MS. The results of the ICP- MS analysis is shown in the upper part of the following table. The column "extraction" means x % of the rare earth metal amount present in the aqueous solution have been extracted into the dichlormethane phase. at heavier, smaller rare earth metal cations were better extracted than big ones
Metal amount in sample extraction
metal
g mmol %
La 2,1082 0,0152 13,35
aqueous Ce 1,8155 0,0130 23,53
solution Nd 1,5015 0,0104 37,85
after Sm 1,2778 0,0085 47,09
extraction Eu 1,3968 0,0092 43,44
Yb 1,0898 0,0063 64,01
La 2,4330 0,0175
aqueous Ce 2,3741 0,0169
solution Nd 2,4159 0,0167 —
prior to Sm 2,4149 0,0161
extraction Eu 2,4693 0,0162
Yb 3,0279 0,0175

Claims

Claims
1 . Monosubstituted oxalic acid derivatives of the general formula (I) [A]+ [0-C(0)-C(0)-0-X]- (I)
Wherein the meaning is for
[A]+ a cation made from an organic moiety A having a formally positively charged het- eroatom selected from the group consisting of nitrogen, phosphorus and sulfur
X is a Ci to C30 organic residue and wherein the following compounds (I) are disclaimed:
Tetramethylammonium monomethyloxalate
Methyltri(alkyl)ammonium monomethyloxalate
Trimethyl(1 -hydroxyethyl)ammonium monomethyloxalate
Methyltriethylammonium monomethyloxalate
Tetraethylammonium monomethyloxalate
n-Propyltriethylammonium mono-n-propyloxalate
n-Butyltriethylammonium mono-n-butyloxalate
Benzyltriethylammonium monobenzyloxalate
cyclohexyldimethylammonium monomethyloxalate
Dimethyl-phenylammonium monomethyloxalate.
Tetrabutylammonium monomethyloxalate
N-methylpyridinium monomethyloxalate
N-ethylpyridinium monoethyloxalate
N-n-propylpyridinium mono-n-propyloxalate
N-n-butylpyridinium mono-n-butyl-oxalate
N-benzylpyridinium monobenzyloxalate
N-methyl-isochinolinium monomethyloxalate
N-ethyl-isochinolinium monoethyloxalate
N-n-propyl-isochinolinium mono-n-propyloxalate
N-n-butyl-isochinolinium mono-n-butyloxalate
N-benzyl-isochinolinium monobenzyloxalate. Monosubstituted oxalic acid derivatives of the general formula (I) as claimed in claim 1 , wherein [A]+ is selected from amongst the compounds of the formulae (IV. e), (IVs), (IVv) and (IVy)
Figure imgf000042_0001
(IV.e)
Figure imgf000042_0002
(IV.s)
R
R2\ ,R°
N N'
R°
(IV.v) R2
3 l+ 1
R— P— R
I
R
(IV.y) wherein the substituents have the following meaning for the formulae:
R in any case is a Ci to C30 organic residue for imidazolium ions (IVe)
R1 is hydrogen, methyl, ethyl, 1 -propyl, 1 -butyl, 1 -pentyl, 1 -hexyl, 1 -octyl, dodecyl,
2-hydroxyethyl or 2-cyanoethyl and R2 to R4 are each, independently of one another, hydrogen, methyl or ethyl; for pyrrolidinium ions (IVs)
R1 is hydrogen, methyl, ethyl, butyl or phenyl and R2 to R9 are each, independently of one another, hydrogen or methyl; for guanidinium ions (IVv)
R1 to R5 are methyl, ethyl or butyl; for phosphonium ions (IVy)
R1 to R3 are each, independently of one another, Ci-Ci8-alkyl.
Monosubstituted oxalic acid derivatives, as claimed in claim 2, wherein X is selected from the group consisting of unsubstituted straight chain or branched Ci to C30 alkyl residues.
Monosubstituted oxalic acid derivatives as defined in claim 1 to 3, wherein they are in the state of an ionic liquid. 5. Process for the preparation of monosubstituted oxalic acid derivatives as defined in claims 1 to 3 wherein the non-quaternized precursor of the organic moiety A as defined in claims 1 to 3 is reacted with an oxalic acid compound of the general formula (II)
R10-C(0)-C(0)-0-X (II) wherein R1 and X the same or different are a Ci to C30 organic residue.
Use of the monosubstituted oxalic acid derivatives as defined per the general formula (I) in claims 1 to 3 for at least partially dissolving an inorganic or an organic material.
Use as claimed in claim 6, wherein the inorganic or organic material is a metal compound
Use as claimed in claim 7, wherein the metal is a rare earth element or an actinide element.
Use of the monosubstituted oxalic acid derivatives as defined per the general formula (I) in claims 1 to 3 in a separation process for metals.
Use as claimed in claim 9, wherein the metals are rare earth elements and actinide elements.
1 1 . Use as claimed in claims 9 to 10 wherein the separation process is a liquid-liquid extraction.
PCT/EP2013/070824 2012-10-10 2013-10-07 Ionic liquids based on oxalic acid mono esters WO2014056844A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12187948 2012-10-10
EP12187948.0 2012-10-10

Publications (1)

Publication Number Publication Date
WO2014056844A1 true WO2014056844A1 (en) 2014-04-17

Family

ID=47010380

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/070824 WO2014056844A1 (en) 2012-10-10 2013-10-07 Ionic liquids based on oxalic acid mono esters

Country Status (1)

Country Link
WO (1) WO2014056844A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2940010A1 (en) * 2014-04-29 2015-11-04 Basf Se Ionic liquids based on oxalic acid mono amides
CN106187900A (en) * 2016-07-08 2016-12-07 南方科技大学 Prepare method and the purposes of carboxylic acid type ionic liquid of carboxylic acid type ionic liquid
US10669261B2 (en) 2015-12-16 2020-06-02 Bristl-Myers Squibb Company Heteroarylhydroxypyrimidinones as agonists of the APJ receptor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033945A1 (en) 2007-09-06 2009-03-11 Infineum International Limited Quaternary ammonium salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033945A1 (en) 2007-09-06 2009-03-11 Infineum International Limited Quaternary ammonium salts

Non-Patent Citations (20)

* Cited by examiner, † Cited by third party
Title
BILLARD ET AL., ANAL BIOANAL CHEM., 2011, pages 1555 - 1566
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1968, VASHKOV, V. I. ET AL: "Bactericide properties of quaternary ammonium salts with organic anions", XP002715727, retrieved from STN Database accession no. 1968:485665 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1977, PETYUNIN, G. P. ET AL: "Reaction of aminopyridines and aminoquinolines with oxalic and oxamic acid esters", XP002715726, retrieved from STN Database accession no. 1977:423007 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1980, PETYUNIN, G. P.: "Synthesis and properties of tert-butylammonium monoalkyl oxalates and oxamates", XP002715725, retrieved from STN Database accession no. 1980:585704 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1981, PETYUNIN, G. P. ET AL: "Reaction of aminoadamantanes with esters", XP002715724, retrieved from STN Database accession no. 1981:532343 *
DOLENK; MODEC, ACTA CHIM. SLOV., vol. 55, 2008, pages 752
I BILLARD ET AL., RADIOCHIM ACTA, 2009, pages 355 - 359
ISABELLE BILLARD ET AL: "Liquidâ liquid extraction of actinides, lanthanides, and fission products by use of ionic liquids: from discovery to understanding", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, SPRINGER, BERLIN, DE, vol. 400, no. 6, 4 January 2011 (2011-01-04), pages 1555 - 1566, XP019902260, ISSN: 1618-2650, DOI: 10.1007/S00216-010-4478-X *
KAMETANI ET AL., J. HETEROCYL. CHEM., vol. 3, 1966, pages 129
KAMETANI ET AL., YAKUGAKU ZASSHI, vol. 88, 1968, pages 445
KO NAKAMURA ET AL.: "Creatones A and B. revision of the structure for the product of oxidation of creatinine and creatine", BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, vol. 63, 1990, pages 1540 - 1542, XP002715723 *
NAZAR-UL-ISLAM ET AL: "Electro-organic reactions. part 28. preparative applications of the oxalate cathodic cleavage reaction including one-pot conversions of aldehydes and ketones", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 43, no. 12, 1 January 1987 (1987-01-01), pages 2741 - 2748, XP026614837, ISSN: 0040-4020, [retrieved on 19870101], DOI: 10.1016/S0040-4020(01)86879-4 *
PETYUNIN G P ET AL: "PREPARATION OF AMINOACRIDINE SALTS", PHARMACEUTICAL CHEMISTRY JOURNAL, SPRINGER NEW YORK LLC, US, vol. 9, no. 7, 1 July 1975 (1975-07-01), pages 444 - 447, XP009037755, ISSN: 0091-150X, DOI: 10.1007/BF00759350 *
PETYUNIN, G. P. ET AL: "Reaction of aminoadamantanes with esters", UKRAINSKII KHIMICHESKII ZHURNAL (RUSSIAN EDITION) , 47(5), 536-9 CODEN: UKZHAU; ISSN: 0041-6045, 1981 *
PETYUNIN, G. P. ET AL: "Reaction of aminopyridines and aminoquinolines with oxalic and oxamic acid esters", UKRAINSKII KHIMICHESKII ZHURNAL (RUSSIAN EDITION) , 43(4), 400-3 CODEN: UKZHAU; ISSN: 0041-6045, 1977 *
PETYUNIN, G. P.: "Synthesis and properties of tert-butylammonium monoalkyl oxalates and oxamates", FARMATSEVTICHNII ZHURNAL (KIEV) , (3), 40-2 CODEN: FRZKAP; ISSN: 0367-3057, 1980 *
VASHKOV, V. I. ET AL: "Bactericide properties of quaternary ammonium salts with organic anions", TRUDY TSENTRAL'NOGO NAUCHNO-ISSLEDOVATEL'SKOGO DEZINFEKTSIONNOGO INSTITUTA , NO. 18(PT. 1), 96-9 CODEN: TTDIA9; ISSN: 0372-2031, 1967 *
WIIISTATTER; KAHN, BER. CHEM. GESELL., vol. 35, 1902, pages 2757
X. SUN ET AL., TALANTA, 2012, pages 132 - 137
XIAOHU DENG ET AL: "Practical Synthesis of a Cathepsin S Inhibitor: Route Identification, Purification Strategies, and Serendipitous Discovery of a Crystalline Salt Form", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 75, no. 6, 19 March 2010 (2010-03-19), pages 1940 - 1947, XP055086016, ISSN: 0022-3263, DOI: 10.1021/jo902650b *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2940010A1 (en) * 2014-04-29 2015-11-04 Basf Se Ionic liquids based on oxalic acid mono amides
US10669261B2 (en) 2015-12-16 2020-06-02 Bristl-Myers Squibb Company Heteroarylhydroxypyrimidinones as agonists of the APJ receptor
CN106187900A (en) * 2016-07-08 2016-12-07 南方科技大学 Prepare method and the purposes of carboxylic acid type ionic liquid of carboxylic acid type ionic liquid
WO2018006495A1 (en) * 2016-07-08 2018-01-11 南方科技大学 Method for preparing carboxylate-type ionic liquid and use of carboxylate-type ionic liquid

Similar Documents

Publication Publication Date Title
US20100267596A1 (en) Method for improving the hydrolysis stability of ionic liquids
JP2010516265A (en) Process for producing glucose by enzymatic hydrolysis of cellulose pretreated with ionic liquids with polyatomic anions
EP2379684A2 (en) Mixtures of hydrophobic and hydrophilic ionic liquids and use thereof in liquid ring compressors
AU2008208870B2 (en) Method for producing glucose by enzymatic hydrolysis of cellulose that is obtained from material containing ligno-cellulose using an ionic liquid that comprises a polyatomic anion
EP1651614B1 (en) Method for the production of purified 1,3-substituted imidazolium salts
US20100297532A1 (en) Process for working up ionic liquids
WO2014207100A1 (en) A process for coating paper with cellulose using a solution containing cellulose
US20140099249A1 (en) Ionic liquids based on oxalic acid mono esters
US8410327B2 (en) Process for isomerizing a saturated, branched and cyclic hydrocarbon
DE102006028165A1 (en) Process for the acylation of cellulose
WO2008119770A1 (en) Method for modifying the structure of a cellulose material by treatment with an ionic liquid
EP3134380B1 (en) Method for producing carboxylic acid esters in the presence of an ionic liquid and an acidic esterification catalyst and the use thereof as plasticizer
DE102005017733A1 (en) Solubility of cellulose in ionic liquids with the addition of amine base
WO2014056844A1 (en) Ionic liquids based on oxalic acid mono esters
DE102006011075A1 (en) Process for breaking down cellulose in solution
WO2007101812A1 (en) Method for breaking down cellulose
DE102005055815A1 (en) Process for the preparation of ionic liquids
EP2940010A1 (en) Ionic liquids based on oxalic acid mono amides
WO2010000834A1 (en) Use of ionic liquids as catalysts
DE102009051087A1 (en) Working medium, useful for cooling- and heating processes and for operating e.g. absorption heat pump, comprises an ionic liquid as an absorbent comprising tetra(alkyl)ammonium cation and a cooling- or heating agent
US20230042328A1 (en) Ionic liquid for stabilizing viscosity of silicate-based coatings
DE102009049696A1 (en) New hole conductor material containing compounds useful e.g. as semiconductor material, preferably p-semiconductor in a solar cell, preferably dye photovoltaic cell, ionic liquid, solvent for chemical reaction and heat carriers
JP2012005383A (en) Method of decomposing cellulose

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13773265

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13773265

Country of ref document: EP

Kind code of ref document: A1